Advertisement

Chemotherapy of Gastrointestinal Nematodiasis in Man

  • P. G. Janssens
Part of the Handbook of Experimental Pharmacology book series (HEP, volume 77)

Abstract

Intestinal worms have always been and are still problems for humans. The awareness of practitioners has been generally limited to the helminths occurring within their own field of activity.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Abadi K (1974) Mebendazole (R 17635) in the treatment of intestinal helminthiasis in low socio-economic group in Ujung Pandang, South Sulawesi. Janssen Pharmaceutica Clin Res Report, N 8 250Google Scholar
  2. Abadie DH, Samuels M (1965) A fatality associated with dithiazanine iodide therapy. J Am Med Assoc 192:326–327Google Scholar
  3. Abdallah A (1959) Epidemiology of ancylostomiasis. J Min Health 1:4–12Google Scholar
  4. Abdallah A, Saif M (1963) The efficacy of single-dose treatment of ancylostomiasis with bephenium hydroxynaphtoate. J Trop Med Hyg 66:45–47PubMedGoogle Scholar
  5. Adam W, Janssens PG (1965) L’Ankylostomiase. Rev Hyg Mines 20:101–125Google Scholar
  6. Adiao AC, Mejia SS, Mundo F Del (1961) Clinical observations on the use of pyrvinium pamoate in enterobiasis. J Philipp Med Assoc 37:485–488Google Scholar
  7. Aguilar FJ (1959) The polyanthelmintic action of dithiazanine iodide. Am J Trop Med Hyg 8:305–306PubMedGoogle Scholar
  8. Aguilar FJ (1981) Helminthiasis humanas transmitidas a través del suelo en Guatemala. Bol ChilParasitol 36:6–9Google Scholar
  9. Aguilar FJ, Tanchez G, Cifuentes CE, Folgar M (1973) Trichuriasis: tratamiento con mebendazole. Rev Coleg Medico 24:182–184Google Scholar
  10. Aguilar FJ, Cifuentes CE, Samayoa A (1977) Comparative clinical study: Oxantel- pyrantel, mebendazole in uncinariasis, trichuriasis and ascariasis. 4th Congr latino americano San José, Costa-Rica (1976). Parasitologia 28:101–118Google Scholar
  11. Ahmad N, Ghulam R (1959) Bephenium hydroxynaphtoate against hookworm in West Pakistan. J Trop Med Hyg 12:284Google Scholar
  12. Ahmad N, Rasool G (1959) Bephenium hydroxynaphtoate against hookworm in West-Pakistan. J Trop Med Hyg 62:284–285PubMedGoogle Scholar
  13. Ahmad N, Keeling JED, Wahid A (1964) A clinical trial of two bephenium hydroxynaphtoate preparations against hookworm and roundworm in West-Pakistan. Am J Trop Med Hyg 13:693–697PubMedGoogle Scholar
  14. Akagi K (1973) Enterobius vermicularis and enterobiasis. In: Marishita et al. (eds) Progress of medical parasitology in Japan, vol 5. pp 229–279Google Scholar
  15. Albos Martinez J, Arce L (1956) La piperacina en el tratamiento de las helminthiasis inte- stinales. Med Clin 27:350–354Google Scholar
  16. Alekseeva MI, Pucenko AY (1980) Comparative effectiveness and tolerance in the Van- quin, Combatrin and Vermox treatments of enterobiasis. Med Parazitol 49:34–38Google Scholar
  17. Alexander F, Drijkoningen G, Flahaut J, Raveschot H (1970) Comparative study of the therapeutic efficacy and tolerance of pyrvinium pamoate and pyrantel pamoate in Enterobius vermicularis infections (in Dutch). Tijdschr Geneeskd 26:333—335Google Scholar
  18. Alicata JE, Jindrak K (1970) Angiostrongylosis in the Pacific and Southeast Asia. Thomas, SpringfieldGoogle Scholar
  19. Al-Issa TB, Wahab HA (1971) Comparative trial of pyrantel, levamisole and bephenium in the treatment of intestinal worms in Iraq. Bull EndemDis 18:109–115Google Scholar
  20. Al-Saffar G, Al-Saleem M, Bakhous IJ (1971) L-Tetramisole in the treatment of ancylostomiasis. Trans R Soc Trop Med Hyg 65:836—837PubMedGoogle Scholar
  21. Amato-Neto V (1969) Sintomatologia atribuivel a enterobiasis. Rev Inst Med Trop Sao Paulo 11:343–347PubMedGoogle Scholar
  22. Amato-Neto V (1970) Oxantel-pyrantel. Rev Inst Med Trop Sao Paulo 12:207–210PubMedGoogle Scholar
  23. Amato-Neto V, Correa M (1956) Tratamento da ascaridiase pelo hydrato de piperazina. O Hospital 49:103–107Google Scholar
  24. Amato-Neto V, Moura-Vasconcellos AT De (1965) Tratamento da trichocefaliase pelo as- sociago de Tiabendazole e pamoato de pirvinio. O Hospital 68:1413–1418Google Scholar
  25. Amato-Neto V, Wanderley RA, Correa MO A (1967) Traitement des porteurs d’Ascaris par le tetramisole dans une zone rurale. O Hospital 72:585–591PubMedGoogle Scholar
  26. Amato-Neto V, Levi GC, Vilela E, Oliveira Gomes MC De, Campos R (1969a) Sintomatologia atribuivel à enterobiase, analisada entre criangas residentes em habitacao coletiva. Rev Inst Med Trop Sao Paulo 11:343–347PubMedGoogle Scholar
  27. Amato-Neto V, Levi GC, Aly J, Correa MOA (1969b) Observacoes sobre a atividade curativa da forma levogyra do tetramisole (RO 8299.L) en relagao a ascaridase. O Hospital 75:171–176Google Scholar
  28. Amato-Neto V, Levi GC, Stefani NV, Konichi SR, Dias JCP, Oliveira LR, Campos LL (1973) Nossas primeiras observacoes sobre a acao terapeutica de mebendazole novo medicamento anti-helmintico dotado de amplo espectro de atividade. Rev Inst Med Trop Sao Paulo 15:34–37PubMedGoogle Scholar
  29. Amato-Neto V, Sinto T, Pedro RJ, Levi GC, Tsukumo MKK, Moraes VMC, Correa LL (1978) Nossas observacoas iniciais sobre a efficacia do cambendazole no tratamento da estrongiloidiase. Rev Inst Med Trop Sao Paulo 20:161–163PubMedGoogle Scholar
  30. Amato-Neto V, Mareira AA, Campos R, Lazarro ES, Chiaramelli MC, Castillo VL, Gomes AE, Pinto PL (1983) Tratamento da ancilostomiase por meio da albendazol. Rev Inst Med Trop Sao Paulo 25:42–46PubMedGoogle Scholar
  31. Ambre S, Mak JW (1981) The effect of mebendazole and flubendazole on Angiostrongylus malaysiensis infections in rats. Southeast Asian J Trop Med Public Health 12:228–280Google Scholar
  32. Andrade Freire D, Oetting A Jr, Machado Freire E, Cubero Ruano A, Amato-Neto V (1969) Tratamento da ascaridiase por meio do levamisole-base. O Hospital 76:1715’1719Google Scholar
  33. Anthony PP, McAdam IWJ (1972) Helminthic pseudotumours of the bowel: thirty-four cases ofhelminthoma. Gut 13:8–16PubMedGoogle Scholar
  34. Anuar A Kh, Ramachandran CP (1977) A study on the prevalence of soil transmitted helminths among lettuce leaves sold in local markets in Penang (Malaysia). Med J Malaysia 31:262–265PubMedGoogle Scholar
  35. Apt W, Hisamoto T, Llorens P, Alcaino H (1980) Anisakiasis gastrica in Chile. Rev Med Chil 108:825–827PubMedGoogle Scholar
  36. Arada III EV, Augustin EC, Bagasao MG, Chung EO, Diadula HM, Ibarra AN, Libarnes RL, Lim AC, Padilla EP, Tan ES (1978) A double blind comparative study of the efficacy of mebendazole and flubendazole in the treatment of enterobiasis. J Manila Med Soc 16:39–46Google Scholar
  37. Arfaa F, Farahmandian I (1976) Progress achieved in the chemotherapy of soil-transmitted helminths. In: Williams JD, Geddes AM (eds) Chemotherapy 6:11–22Google Scholar
  38. Arfaa F, Ghadirian E (1977) Epidemiology and mass-treatment of ascariasis in six rural communitees in central Iran. Am J Trop Med Hyg 26:866–867PubMedGoogle Scholar
  39. Arfaa F, Ghadirian E (1978) The effect of mass-treatment in the control of helminthiasis in Ispahan, central Iran. Iran J Public Health 7:100–114Google Scholar
  40. Arfaa F, Sahba GH, Farahnandian I, Jalali H (1977) Evaluation of the effect of different methods of control of soil-transmitted helminths in Khuzestan, southwest Iran. Am J Trop Med Hyg 26:230–233PubMedGoogle Scholar
  41. Arfaa F, Farahmandian I, Miller MJ (1979) Flubendazole in the treatment of hookworm disease complicated or not by trichuriasis and/or ascariasis. Janssen Pharmaceutica, Clin Res Report, N 17494Google Scholar
  42. Arguedas JA, Villarejos VM, Swartzwelder JC, Chavarria AP, Zeledon R, Koteher E (1975) Community control of Strongyloides stercoralis by thiabendazole. Tex Rep Biol Med 33:265–268PubMedGoogle Scholar
  43. Asami KT, Watanuki H, Sakai H, Smano H, Okamoto R (1963) Two cases of stomach granuloma caused by Anisakis-like larval nematodes in Japan. Am J Trop Med Hyg 14:119–123Google Scholar
  44. Asford RW, Hall A J, Babona D (1981) Distribution and abundance of intestinal helminths in man in Western Papua New Guinea with special reference to strongyloides. Ann Trop Med Parasitol 75:269–279Google Scholar
  45. Asmera J (1974) Decaris Janssen — evaluation of clinical trials. Janssen Pharmaceutica, Clin Res RepN 5166Google Scholar
  46. Aspöck H, Flamm H, Picher O, Wiedermann G (1977) Mebendazol — Ein polyvalentes Antihelminthicum für die ambulante Entwurmung. Wien Med Wochenschr 127:88–91PubMedGoogle Scholar
  47. Asshauer E, Mohr W (1966) Thiabendazol in der Behandlung von Wurminfektionen. Arzneimittelforsch 16:428–431PubMedGoogle Scholar
  48. Aswapoker N, Saravich S (1978) Mebendazole, a new broad spectrum anthelminthic. J Med Assoc Thai 61:675–680Google Scholar
  49. Atchley FO, Wysham DN, Hemphill EC (1956) Mass treatment of Ascariasis with a single dose of piperazine citrate. Am J Trop Med Hyg 5:881–887PubMedGoogle Scholar
  50. Atra E, Vilela MP de, Zucas AW (1965) Therapeutica da trichocephaliase. Resultados ob- tidas com una nova associagao medicamentosa em adultos. O Hospital 61:217–224Google Scholar
  51. Avery JL (1956) Treatment of enterobiasis with one oral dose of promethazine hydrochloride. JAMA 161:681–683Google Scholar
  52. Ayad El-Masry N, Trabolsi B, Bassily S, Farid Z (1983) Albendazole in the treatment of Ancylostoma duodenale and Asearis lumbricoides infections. Trans R Soc Trop Med Hyg 77:160–161Google Scholar
  53. Bächlin A, Degremont A (1979) Oxyuren Befall in Basler Kindergärten. Schweiz Rundschau Med 68:1183–1185Google Scholar
  54. Baer JG (1951) Ecology of animal parasites. University of Illinois Press, UrbanaGoogle Scholar
  55. Baker NF, Walters CT (1971) Antihelmintic efficacy of cambendazole in cattle. Am J Vet Res 32:29–33PubMedGoogle Scholar
  56. Balagopal R (1974) Study of oxyuriasis in families. Inst Child Health, MadrasGoogle Scholar
  57. Madras Baldez D, Conti LMZ, Sette PC, Sette H, Silva LC Da, Saez-Alquezar A (1978) Flubendazole no tratamento das parasitoses intestinais: comparacao entre dois esquemas posologicas. Ann XIV congresso Soc Brasiliera de Med Trop, Joao PessoaGoogle Scholar
  58. Bannerjee D, Prakash O, Kaliyugaperumal V (1972a) A clinical trial of mebendazole (R 17 635) in cases of hookworm infection. Indian J Med Res 60:562–566Google Scholar
  59. Bannerjee D, Kaliyugaperumal V, Prakash O (1972b) Tetramisole in hookworm infections. Indian J Med Res 60:834–839Google Scholar
  60. Banzon TC, Singson CN, Cross JH (1976) Mebendazole treatment for intestinal nematodes in a Philippine Barrio. A preliminary report. J Philipp Med Assoc 52:7–8Google Scholar
  61. Baranski MC, Silva AF Da, Kotaka PI, Gomes NR, Giovannoni M, Teiles JEQ (1978) Tratamento da estrongiloidiase humana com novo antihelmíntica, o cambendazole. Estudo Duplo cegó. Rev Inst Med Trop Sao Paulo 20:213–218PubMedGoogle Scholar
  62. Baranski MC, Fontoura A da, Guimaraes LM (1981) Tratamiento de las helminthiasis intestinales con Albendazol, un nuevo antihelmíntico del grupo de los benzimidazoles. Estudio doble ciego. Compendium Invest Clin latino americanos [Suppl] 1:82–89Google Scholar
  63. Barbaix E (1981) Flubendazole in the treatment of trichuriasis, ascariasis and hookworm disease. Janssen Pharmaceutica, Clin Res Report, N 24062Google Scholar
  64. Barrett-Connor E (1975) Recent advances in the treatment of common intestinal helminths. Am J Gastroenterol 63:105–116PubMedGoogle Scholar
  65. Basnuevo JG, Kowin A (1959) Accion antihelminthia del Yoduro de Ditiazanina. Rev Kuba Med Trop 15:27–36PubMedGoogle Scholar
  66. Basnuevo JG, Delgado FS, Fontao JA (1953) La mezcla hexilresorecinol — tetracloroetileno sustituye ventajosamente al helecho macho en el tratamiento de la taeniaisis. Rev Kuba Med Trop 9:48–50PubMedGoogle Scholar
  67. Basnuevo JG, Rodrigues JJ, Borbolla L (1959a) Tratamiento de la strongyloidiasis con ditiazanina. Rev Kuba Med Trop 15:5–8Google Scholar
  68. Basnuevo JG, Rodrigues JJ, Borges F (1959b) Tratamiento de lo trichocefaliasis con ditia- zanine. Rev Kuba Med Trop 15:15–19Google Scholar
  69. Bastidas GrJ (1982) Albendazol a dosis unica en nematodiasis intestinales multiples. Invest Med Intern 9:308–312Google Scholar
  70. Batzinger RP, Bueding E, Crawford K, Bruce J (1979) Prevention of the mutagenic activation of antischistosomal isothiocyanate in primates by an antibiotic. Environ Mutagen 1:353–360PubMedGoogle Scholar
  71. Bawa YS, Chopra JS, Sharma TD (1965) Comparative study of bephenium hydroxynaphtoate and tetrachlorethylene in hookworm disease. Indian J Med Sci 19:605–608PubMedGoogle Scholar
  72. Beck JW (1964) Treatment of pinworm infections with reduced single dose of pyrvinium pamoate. JAMA 189:511PubMedGoogle Scholar
  73. Beck JW (1966) The treatment of Ascaris lumbricoides and Enterobius vermicularis with combination drug composed of Pyrvinium pamoate and piperazine. Acta Med Costaricense 9:9–11Google Scholar
  74. Beck JW, Saavedra D, Antell GJ, Tefeiro B (1959) The treatment of pinworm infections in humans with pyrvinium chloride and pyrvinium pamoate. Am J Trop Med Hyg 8:349–352PubMedGoogle Scholar
  75. Becquet R (1963) Traitement de l’ankylostomose par l’hydroxynaphtoate de bephenium. J Sci Méd (Lille) 81:316–321Google Scholar
  76. Becquet R (1976) Expertise clinique ’ flubendazole comprimés. Janssen Pharmaceutica, Clin Res Report R 17889/G,N 12249Google Scholar
  77. Becquet R, Labarriere F (1980) Le flubendazole dans le traitement des nématodoses digestives. Méd Actuelle 7:4Google Scholar
  78. Behar RR (1971) Eratamiento de la estrongiloidiasis en la infancia. Rev Cubana Med Trop 23:141–150Google Scholar
  79. Beheyt P, Lebrun A, Cerf J, Dierick J, Groote V De (1961) Toxicity for man of an organo phosphorus insecticide. Bull WHO 24:465–173PubMedGoogle Scholar
  80. Bekhti A (1974) Un nouvel anthelminthique, le mebendazole. Acta Gastroenterol Belg 37:302–306PubMedGoogle Scholar
  81. Bell WJ, Gould GC (1971) Preliminary report on pyrantel pamoate in the treatment of human hookworm infection. East Afr Med J 48:143–151PubMedGoogle Scholar
  82. Bell WJ, Nassif S (1971) Comparison of pyrantel pamoate and piperazine phosphate in the treatment of ascariasis. Am J Trop Med Hyg 20:584—588PubMedGoogle Scholar
  83. Bellani L, Mantovani A, Pampiglione S, Filippini I (1978) Observations on an outbreak of human trichinellosis in Northern Italy. In: Kim ChW, Pawlowski ZP (eds) Trichinellosis. University Press of New England. Hannover, New Hampshire, pp 535–539Google Scholar
  84. Beltran-Hernandez F, Sanchez-Carrillo C, Caballero-Guerrero C (1976) Control de las helminthiasis transmitidas por el suelo (HTS) con Mebendazole, en una communidad de la Selva Lacandona (Mexico). 4th congr latino americano de parasitol, San Jose, Costa RicaGoogle Scholar
  85. Berti JJ, Silva H, Simonovis A De (1976) Evaluación del mebendazol y de la combinación oxantel-pyrantel en el tratamiento de helminthiases intestinales. 4th Congr Latino americano de parasitol, San José, Costa RicaGoogle Scholar
  86. Bettecken F (1957) Über EEG-Veränderungen durch Piperazin im Kindesalter. Z Kinderheilk 80:225–231PubMedGoogle Scholar
  87. Bezjak Br (1968) A clinical trial of thiabendazole in strongyloidiasis. Am J Trop Med Hyg 17:733–736PubMedGoogle Scholar
  88. Bhaibulaya M, Indra-Ngarm S (1979) Amaurornis phoenicurus and Ardeola bacchus as experimental definitive hosts for Capillaria philippinensis in Thailand. Int J Parasitol 9:321–322PubMedGoogle Scholar
  89. Bhaibulaya M, Punnavutti V, Yamput S (1975) Mass treatment of hookworm infection with a single dose of pyrantel pamoate. J Med Assoc Thai 59:347–350Google Scholar
  90. Bhaibulaya M, Benjapong W, Noeypatimanond S (1977) Infection of Capillaria philippinensis in man from Phetchabun Province, northern Thailand: a report of the fifth case. J Med Assoc Thai 69:507–509Google Scholar
  91. Bhaibulaya M, Indra-Ngarm S, Anathapruti M (1979) Freshwater fishes of Thailand as experimental intermediate hosts for Capillaria philippinensis. Int J Parasitol 9:105–108Google Scholar
  92. Bhandari B, Shrimali LN (1969) Clinical evaluation of phenylene di-isothiocyanate (Jonit ®) in paediatric patients with hookworm disease. J Trop Med Hyg 72:164–166PubMedGoogle Scholar
  93. Bhandari B, Singhi SV (1969) Phenylene di-isothicocyanate in the treatment of adult patients infected with hookworm. Ann Trop Med Parasitol 63:177–180PubMedGoogle Scholar
  94. Bhandari B, Singhi A (1980) Fenbendazole (Hoe 881) in enterobiasis. Trans R Soc Trop Med Hyg 74:691PubMedGoogle Scholar
  95. Biagi F (1980) Levamisol en el tratmiento de la ascariasis. Janssen Pharmaceutica, Int Clin Res Report, N 19198Google Scholar
  96. Biagi F, Rodrigues O (1960) A study of ascariasis eradication by repeated mass treatment. Am J Trop Med Hyg 9:274–276PubMedGoogle Scholar
  97. Biagi F, Zavala J, Malagon F (1969) Accion antiparasitaria del connuesto 16842 en la un- cinariaris y trichocefalosis. Rev Inst Med Trop Sao Paulo 11:444–448PubMedGoogle Scholar
  98. Biagi F, Smyth J, Gonzalez C (1974) Mebendazole en helminthiasis intestinales. La Prensa Med Mexicana 39:3–5Google Scholar
  99. Bicalho SA, Leao OJ, Pena Q Jr (1983) Cambendazole in the treatment of human strongyloidiasis. Am J Trop Med Hyg 32:1181–1183PubMedGoogle Scholar
  100. Biguet J, Deblock S, Capron A, Mâchez JM (1952) La cure éclair de l’oxyurose par le pamoate de pyrroviniquinium. Presse Méd 67:1739–1740Google Scholar
  101. Biguet J, Coutelen F, Deblock S, Doby JM, Mullet S (1953) Etude de l’activité de la pipérazine dans l’oxyurose. Bull Soc Pathol Exot Filiales 48:40–46Google Scholar
  102. Bijkerk H (1969) Haringwormziekte (Anisakiasis). Ned Tijdschr Geneeskd 113:906–907PubMedGoogle Scholar
  103. Bijkerk H (1970) Haringwormziekte. Ned Tjdschr Geneeskd 114:856Google Scholar
  104. Bijkerk H (1971) Haringwormziekte (Anisakiasis). Ned Tijdschr Geneeskd 115:763Google Scholar
  105. Bina JC, Figueiredo JFM, Barreto Ailho A, Carvalho F (1977) Tratamento en massa, por meio do mebendazol das helminthiases intestinais mas comuns en meio rural, con estudo dos indices de reinfestacao. Rev Inst Med Trop Sao Paulo 19:47–51PubMedGoogle Scholar
  106. Blechman MG (1975) Clinical effectiveness of mebendazole in the treatment of trichuriasis. CurrTherRes 18:800–803PubMedGoogle Scholar
  107. Blechman MG, Pena-Chavarria A, Diermissen AG (1982) Double-blind study of flubendazole in the treatment of Trichuris trichiura infection. Clin Res Rev 2:115–120Google Scholar
  108. Bogojawlenski NA, Demidova AJ (1928) Sur la présence dans la mucus nasal de l’homme des oeufs de vers parasites. Russian J Trop Med 6:153–156 (in Russian, French summary)Google Scholar
  109. Bonnefoy X, Isautier H (1978) Variations de l’incidence des helminthiases à la réunion en fonction de différents paramètres. Bull Soc Pathol Exot Filiales 71:70—78Google Scholar
  110. Borda CE, Rea MJ, Borda RW (1976) Accion antiparasitaria del mebendazole en la Anquilostomiasis. Prensa Med Argent 63:55–58Google Scholar
  111. Borda CE, Dho MC, Rea MJF, Borda RW (1978) Eficacia del mebendazol en la uncinariasis por Ancylostoma duodenale. Bol Chil Parasitol 33:57–61PubMedGoogle Scholar
  112. Botero D (1964) Report on clinical investigations with thiabendazole. Tribuna Medica 3:1–8Google Scholar
  113. Botero D (1965) Treatment of human intestinal helminthiases with thiabendazole. Am J Trop Med Hyg 14:618–621Google Scholar
  114. Botero D (1922) Possibilities of controlling soil transmitted helminths by mass treatment. Bol Chil Parasitol 34:39–43Google Scholar
  115. Botero D (1975) Epidemiology and public health importance of intestinal nematode infections in Latin America. Fortschr Arzneimittelforsch 19:28–43Google Scholar
  116. Botero D (1980a) Human intestinal Angiostrongylus WHO mimeogr. Int Parasitol S G/ WP/80–25Google Scholar
  117. Botero D (1980b) Treatment on intestinal helminthiasis with flubendazole. Janssen Pharmaceutica, Clin Res Report N 20710Google Scholar
  118. Botero RD, Castano G A (1972) Tratamiento comparativo de uncinariasis y ascariasis com pamoato de Pirantel, hidroxynaftoato de befenio y tetracloretileno. Antioquia Medica 22:581–591Google Scholar
  119. Botero D, Castano A (1973) Comparative study of pyrantel pamoate, bephenium hydroxynaphtoate and tetrachlorethylene in the treatment of Necator americanus infections. Am J Trop Med Hyg 22:45–52PubMedGoogle Scholar
  120. Botero D, Perez CA (1970) Clinical evaluation of a new drug for the treatment of ancylos- tomiasis. Am J Trop Med Hyg 19:471–475PubMedGoogle Scholar
  121. Botero D, Perez AC (1976) Tratamiento de helminthiasis intestinales con mebendazole. Tribuna Medica 54:30–32Google Scholar
  122. Botero D, Orozco HI, Perez A (1966) Ensayo de una mezcla de piperacina y pirvinio en el tratamiento de ascaridiasis y oxyuriasis. Bol Chil Parasitol 21:111–114PubMedGoogle Scholar
  123. Botero-Ramos D (1974) Helmintiasis intestinales. Tratamiento en masa con pamoato de pirantel. Tribuna Medica 50:5, A21–126Google Scholar
  124. Bourderioux C, Chevalier C (1982) Traitement par l’albendazole à Dakar de 85 sujets atteints d’ankylostomose, de trichocéphalose isolée ou d’une association ankylostomose-trichocéphalose, ascaridiose-trichocéphalose. Med Afr Noire 29:23–26Google Scholar
  125. Bouree P, Kouchner G, Gascon A (1976) A propos d’une épidemie de Trichinose dans la banlieu parisienne. Bull Soc Pathol Exot Filiales 69:177–181PubMedGoogle Scholar
  126. Bouree P, Cazin A, Kouchner G (1978) Le fluoromebendazole: nouvel antihelminthique à large spectre. Short communications D3–26. 4th int congress of parasitology. Polish Scientific Publishers, WarszawaGoogle Scholar
  127. Warszawa Bouree P, Bouvier JB, Passeron J, Galanaud P, Dormont J (1979) Outbreak of trichinosis near Paris. Br Med J 1:1047–1049PubMedGoogle Scholar
  128. Bouree P, Thulliez Ph, Kouchner G, Gascon A (1982) Liquid fluorobendazole effectiveness against nematodes. In: Müller M, Gutteridge W, Köhler P (eds) Molecular and biochemical parasitology. Elsevier Biomedical, Amsterdam pp 528Google Scholar
  129. Bouvier JB (1976) Expertise clinique flubendazole compr. Janssen Pharmaceutica, Clin Res Report, N 12247Google Scholar
  130. Bouyer C (1970) Traitement des parasitoses intestinales par le levamisole. Bull Soc Pathol Exot Filiales 63:255–264PubMedGoogle Scholar
  131. Breedveld PH, Geus A De, Jong-Stoelinga MHFM De (1977) Intestinale worminfecties bij migranten uit Suriname. Ned Tijdschr Geneeskd 121:1126—1130PubMedGoogle Scholar
  132. Brock N, Erhardt A, Wilmanns H (1952) Zur Behandlung der Oxyuriasis mit Atrimon. Dtsch Med Wochenschr 77:240–242PubMedGoogle Scholar
  133. Brown HW (1954) The treatment of Ascaris lumbricoides infections with piperazine. J Pediatr 45:419–424PubMedGoogle Scholar
  134. Brown HW (1969) Anthelmintics, new and old. Clin Pharmacol Ther 10:5–21PubMedGoogle Scholar
  135. Brown HW, Chan KF (1955) Treatment of Enterobius vermicularis infections with piperazine. Am J Trop Med Hyg 4:321–325PubMedGoogle Scholar
  136. Brown HW, Cort WW (1927) The egg production of Ascaris lumbricoides. J. Parasitol 14:88–90Google Scholar
  137. Brown HW, Sterman MM (1958) Chemotherapy of strongyloidiasis with pyrrovinyl- quinium (Vanquin). Am J Trop Med Hyg 7:255–256Google Scholar
  138. Brown HW, Chan KF, Yolken H (1956a) Efficacy of promethazine and pyrathiazine against enterobiasis. JAMA 162:1049–1051Google Scholar
  139. Brown HW, Chan KF, Hussey KL (1956b) Treatment of enterobiasis and ascariasis with piperazine. JAMA 161:515–520Google Scholar
  140. Browne DC, Contacos PG, Welch GE, McHardy G (1957) Treatment of Strongyloides stercoralis infection with intravenous gentian violet. Am J Trop Med Hyg 6:1066–1067PubMedGoogle Scholar
  141. Bruch K, Haas J (1976) Effectiveness of single doses of fenbendazole (Hoe 881) against Ascaris, hookworm and Trichuris in man. Ann Trop Med Parasitol 70:205–211PubMedGoogle Scholar
  142. Brudastov AN, Lemelev VR, Kholmukhamedov SK, Krasnosos LN (1971) Clinical picture of the migration phase of ascariasis in self-infection. Med Parazitol 40:165–168Google Scholar
  143. Brugmans JP, Thienpont DC, Wijngaarden I Van, Parijs OF Van, Schuermans VL, Lauwers HL (1971) Mebendazole in enterobiasis. Radiochemical and pilot clinical study in 1,278 subjects. JAMA 217:313–316PubMedGoogle Scholar
  144. Brumpt E (1949) Précês de parasitologic. Masson, ParisGoogle Scholar
  145. Brumpt L (1973) Etude de l’activité du mebendazole dans diverses parasitoses. Janssen Pharmaceutica, Clin Res Report N 7229Google Scholar
  146. Brumpt L (1976) Expertise clinique - flubendazole comprimés -. Intern Clin Report, Janssen Pharmaceutica 12.248Google Scholar
  147. Brumpt L, Ho-Thi-Sang (1953) Le traitement des ankylostomoses graves par le tétrachlor- éthylène. Bull Soc Pathol Exot Filiales 46:1024–1037PubMedGoogle Scholar
  148. Brumpt L, Ho-Thi-Sang (1954) Traitement de l’ascaridose et de l’oxyurose par les derives de piperazine. Bull Soc Pathol Exot Filiales 47:817–822PubMedGoogle Scholar
  149. Brumpt L, Ho-Thi-Sang (1959) La dithiazanine, nouveau vermifuge polyvalent. Presse Mèd 67:289–290PubMedGoogle Scholar
  150. Budzhe MM, Bljuger AF, Dakhovker SF, Ladyznja BS (1959) Comparative study of diverse patterns of ascariasis treatment with piperazine salts. Med Parazitol 28:436–438Google Scholar
  151. Bueding E, Swartzwelder C (1957) Anthelmintics. Pharmacol Rev 9:329–365PubMedGoogle Scholar
  152. Bueding E, Batzinger R, Petterson G (1976) Antischistosomal and some toxicological properties of a nitrodiphenylamino-isothiocyanate (C 9333–90/CGP 4540). Experientia 32:604–606PubMedGoogle Scholar
  153. Bui-Quoc-Huong, Buu-Hoi, Tran-Lu-Y, Tang-Nhiep, Nguyen-Van-Dick, Vu-Dingh- Minh (1962) Activité anthelminthique du 2(4’-thiazolyl) benzimidazole chez l’homme. Chemotherapia 5:326–331PubMedGoogle Scholar
  154. Bumbalo TS, Geist H (1964) The treatment of pin worm infection in a school for the mentally retarded. Am J Trop Med Hyg 13:822–825PubMedGoogle Scholar
  155. Bumbalo TS, Plummer LJ (1957) Piperazine (Antepar) in the treatment of pinworm and roundworm infections. Med Clin North Am 43:575–585Google Scholar
  156. Bumbalo TS, Gustinia F J, Oleksiak RE (1953) The treatment of pinworm infection (enterobiasis). J Pediat 44:386–391Google Scholar
  157. Bumbalo TS, Plummer LJ, Warner JR (1957) Treatment of enterobiasis with one oral dose of promethazine hydrochloride. JAMA 164:1651–1653Google Scholar
  158. Bumbalo TS, Plummer LJ, Warner JR (1958) The treatment of enterobiasis in children. A comparative study of piperazine (Antepar) and pyrvinium chloride (Vanquin). Am J Trop Med Hyg 7:212–214PubMedGoogle Scholar
  159. Bumbalo TS, Fugazzotto DJ, Wyczalek JV (1969) Treatment of enterobiasis with pyrantel pamoate. Am J Trop Med Hyg 18:50–52PubMedGoogle Scholar
  160. Bunnag D (1976) Clinical trial of mebendazole (Vermox) on whipworm, hookworm and Ascaris. Janssen Pharmaceutica Clin Res Rep N 11281Google Scholar
  161. Bunnag D, Harinasuta T, Vasuvat C, Visuthikosol Y, Vidhyanonth C, Chulajata N (1978) Clinical trial of mebendazole (Fugacar) on whipworm and hookworm. 4th int congress of parasitology. Polish Scientific Publishers, Warszawa, D 44Google Scholar
  162. Bunnag D, Harinasuta Tr, Viravan Ch, Jarupakorn V, Chindanond D, Desakorn V (1980) Clinical field trial of flubendazole on hookworm, Trichuris and Ascaris infection. Southeast Asian J Trop Med Public Health 11:363–366PubMedGoogle Scholar
  163. Burriel LM, Fernandes Aguado P, Gomez HO, Bachiller L (1969) Preliminary clinical trial with a new drug (pyrantel) in the treatment of intestinal parasitism by oxyurus. Med Klin (Span, edit) 96:63–67Google Scholar
  164. Burriel LM, Fernandes Aguado P, Gomez Hernandes O, Bachiller L (1973) El problema del diagnostico de la oxiuriasis en pediatrica. Estudio epidemiologico y su tratamiento con el pamoate de pyzantel. Acta Paediatr Espan 31:67–72Google Scholar
  165. Burrows RB, Hunt GR, Lillis WG (1961) A new series of pyridines with anthelminthic activity. J Parasitol [Suppl] 47:35–36Google Scholar
  166. Cabrera BD (1980) Results of clinical trial of mebendazole on soil-transmitted helminthiasis in Cabusao, Naga City, Philippines. A single-dose study comparing 200–400 and 600 mg. Janssen Pharmaceutica, Clin Res Report, N 19 698Google Scholar
  167. Cabrera BD, Cruz AC (1980a) Clinical trial of mebendazole on soil-transmitted helminthiasis in rural communities. Acta Med Philipp 16:55–57Google Scholar
  168. Cabrera BD, Cruz AC (1980b) Clinical trial of oxantel-pyrantel (Quantrel) against trichuriasis. Acta Med Philipp 16:97–102Google Scholar
  169. Cabrera BD, Sy Fr S (1978) Oxantel-pyrantel in various regimens for the treatment of soil transmitted helminthiasis in rural and urban communities. Drugs [Suppl] 15:16–24Google Scholar
  170. Cabrera BD, Garcia EG, Cruz TA, Jueco NL (1960) Treatment of ascariasis with piperazine. J Philipp Med Assoc 36:904–908Google Scholar
  171. Cabrera BD, Canlas B Jr, Danz U (1967) Human intestinal capillariasis III, Parasitological features and management. Acta Med Philipp 4:92–103Google Scholar
  172. Cabrera BD, Juego NL, Cruz TA (1971) Clinical evaluation of levamisole in ascariasis during an intestinal survey at Victoria, Laguna. Janssen Pharmaceutica, Clin Res Rep, N 5167Google Scholar
  173. Cabrera BD, Arambulo III PV, Portillo GP (1975) Ascariasis control and/or eradication in a rural community in the Philippines. Southeast Asian J Trop Med Public Health 6:510–518PubMedGoogle Scholar
  174. Cabrera BD, Valdez EV, Go T (1980) Clinical field trials of broad spectrum anthelminthics against soil-transmitted helminthiasis. Southeast Asian J Trop Med Public Health 11:502–506PubMedGoogle Scholar
  175. Cahill KM (1967) Thiabendazole in massive strongyloidiasis. Am J Trop Med Hyg 16:451’453PubMedGoogle Scholar
  176. Cain GD, Raj RK (1980) Anisakis, Phocanema, Contracaecum and Sulcascarius spp, electrophoresis and thermostability of alcohol and molate dehydrogenases from larvae. Exp Parasitol 49:56–67PubMedGoogle Scholar
  177. Camilo-Coura L, Velho Soli A De S, Lima N Dos Santos, Castro Peixoto TH De, Willcox HPF (1981a) Tratamiento de las helminthiasis intestinales con Albendazol, un deriva- do benzimidazolico nuevo ’ estudio doble ciego. Compendium de investigaciones clinicos Latino-Americanas. In: Simp Latino-Americano geohelminthiasis y albendazol. Cancun, Mexico, pp 67–74Google Scholar
  178. Camilo-Coura L, Velho Soli A De S, Willcox HPF (1981b) Ensayo con Albendazol en el tratamiento de las helminthiasis intestinales de los ninos. Symp. latino americano Geohelminthiasis y Albendazol. In: Compendium de Investigaciones clinicos latino americanos. Cancun, Mexico, pp 75–81Google Scholar
  179. Campbell WC (1961) Effect of thiabendazole upon infections of Trichinella spiralis in mice and upon certain other helminthiases. J Parasitol [Suppl] 47:37Google Scholar
  180. Campbell WC, Blair LS (1974) Chemotherapy of Trichinella spiralis infections (a review). Exp Parasitol 35:304–334PubMedGoogle Scholar
  181. Campbell WC, Cuckler AC (1964) Effect of thiabendazole upon the enteral and parenteral phases of trichinosis in mice. J Parasitol 50:481–488PubMedGoogle Scholar
  182. Campbell WC, Cuckler A (1969) Thiabendazole in the treatment and control of parasitic infections in man. Tex Rep Biol Med [Suppl 2] 27:665–695Google Scholar
  183. Campbell WC, Hartman RK (1968) Changes in the efficacy of three anti-helminthics during the maturation of a nematode (Trichinella spiralis). J Parasitol 54:112–116PubMedGoogle Scholar
  184. Campos R, Croce J, Amato-Neto V (1963) Tratamento da Trichostrongiliase humana pelo thiabendazol. O Hospital 64:261–264Google Scholar
  185. Campos R, Amato-Neto V, Vasconcellos AT de M, Wanderley RA (1967) Tratamento da ascaridiase e da trichocefaliase pelo iodeto de estilbasio. O Hospital 71:703—709PubMedGoogle Scholar
  186. Campos R, Kusninsky N, Scheinberg MA, Pereira W Jr, Inacio V, Paschoalotti MD (1968) Tratamento da ascaridiase com novo derivado piperazinico (di-glicosyl-piperazine) em dosa unica. O Hospital 73:23–26PubMedGoogle Scholar
  187. Canese A, Canese J, Vargas H De, Galeano A, Moleon A, Alsina P (1978) Accion del flubendazol en algunas parasitosis intestinales. Rev Paraguaya Microbiol 13:31–33Google Scholar
  188. Canzonieri CJ (1980) Results obtained in ascariasis with massive periodic treatments with pyrantel pamoate. Prensa Med Argent 67:924–925Google Scholar
  189. Canzonieri CJ, Rodrigues RR, Castillo HE, Ibanez De Baílela C, Lucena M (1977) Ensayos therapeuticos con praziquantel in Taenia saginata e Hymenolepis nana. Bol Chil Parasitol 32:41–42PubMedGoogle Scholar
  190. Carney DE, O’Reilly BJ, Tweddell ED (1971) Pyrantel embónate in the treatment of enterobiasis. Med J Aust 2:254–256PubMedGoogle Scholar
  191. Carr HR, Pichardo Sardo ME, Nunes NA (1954) Anthelmintic treatment of uncinariasis. Am J Trop Med Hyg 3:495–503PubMedGoogle Scholar
  192. Carrie J (1968) Activité du thiabendazole dans le traitement de la strongiloidose. In: 8e Conftechn OCCGE, Bamako, Haute Volta pp 424–428Google Scholar
  193. Carrie J (1978) Activité du mebendazole sur trois parasitoses intestinales. 12e conf techn OCEAC, Yaounde, CamerounGoogle Scholar
  194. Carrie J, Ravinet, Durand B (1978) Essai de controle des helminthiases intestinales. Résultats obtenus par traitement systématique par le mebendazole. 12th conf techn OCEAC, YaoundeGoogle Scholar
  195. Carter FS (1949) Plasma cell hyperplasia and hyperglobulinemia in trichinosis. The duration of larviposition. Am J Pathol 25:309–323PubMedGoogle Scholar
  196. Carter FS (1953) Cerebral cysticercosis. East Afr Med J 30:295–301PubMedGoogle Scholar
  197. Castro LP de, Cunha AS, Ribeiro TC de, Resende HP (1973) Estudo farmacoclinico e terapeutico de um novo anti-helmintico, o Mebendazole (R 17635), em criancas polipa rasitadas. Rev Assoc Med Bras 19:441–446Google Scholar
  198. Cavier R (1963) Recherches sur les propriétés anthelminthiques de l’hydroxy-l-phenothia- zine et des associations phénothiazines + hydrate de pipérazine. Bull Soc Pathol Exot Filiales 56:1049–1055PubMedGoogle Scholar
  199. Cavier R (1973) Chemotherapy of intestinal nematodes. In: Radouco Thomas C (ed) International encyclopedia of pharmacology and therapeutics. Pergamon, Oxford, pp 215–436 (Chemotherapy of helminthiasis, section 64, vol 1, chapter 4)Google Scholar
  200. Cavier R, Bellon R (1960) Essai de traitement de la trichocephalose par le sébacate de pipérazine. Bull Soc Pathol Exot Filiales 53:626–629PubMedGoogle Scholar
  201. Cavier R, Gaulin J (1951) Recherches sur les propriétés anthelminthiques de la piperazine et de quelques uns de ses dérivés. Tunis Med 39:902–905Google Scholar
  202. Cavier R, Hawking F (1973) Chemotherapy of helminthiasis vol I. In: Radouco Thomas C (ed) International encyclopedia of pharmacology and therapeutics. Pergamon, Press OxfordGoogle Scholar
  203. Cavier R, Rossignol JF (1980) Etude comparative des propriétés oxyuricides de l’albenda- zole, du mebendazole, du pamoate de pyrantel et du praziquantel chez la souris expérimentalement infectée. Ann Pharm Fr 40:55–60Google Scholar
  204. Cerf J (1958) Traitement de la strongyloidose par la dithiazanine. Ann Soc Belg Med Trop 38:1027–1030Google Scholar
  205. Cerf J, Lebrun A, Dierickx J (1962) A new approach to helminthiasis control: the use of an organophosphorous compound. Am J Trop Med Hyg 11:514–517PubMedGoogle Scholar
  206. Cervoni W, Oliver-Gonzales J (1971) Clinical evaluation of pyrantel pamoate in helminthiasis. Am J Trop Med Hyg 20:589–591PubMedGoogle Scholar
  207. Cervoni WA, Oliver-Gonzales J (1975) Single oral doses of levamisole and pyrantel pamoate in the treatment of ascariasis: a placebo-controlled comparison for cure and reinfestation rates and for mean egg reduction. Janssen Pharmaceutica, Clin Res Report, N 10240Google Scholar
  208. Cervoni WA, Oliver-Gonzales J, Kaye S, Slomka MB (1969) Dichlorvos as a single dose intestinal anthelminthic therapy for man. Am J Trop Med Hyg 18:912–919PubMedGoogle Scholar
  209. Cespedes R, Salas J, Mekbel S, Troper L, Müllner F, Morera P (1967) Granulomas ente — ricas y limfaticos con intensa eosinofilia tissular, producidos par un estrongilidea (Strongylata). Acta Med Costarne 10:235–255Google Scholar
  210. Chabaud AG (1972) Description de Stefanskostrongylus dubosti n. sp. parasite du potoma- jole et essai de classification des nématodes Angiostrongylinae. Ann Parasitol Hum Comp 47:735–744PubMedGoogle Scholar
  211. Chabaud AG, Lariviere M (1958) Sur les oesophagostomes parasites de l’homme. Bull Soc Pathol Exot Filiales 51:384–393PubMedGoogle Scholar
  212. Chai J-Yi, Hong S-T, Lec S-Hy, Seo By-S (1981) Fluctuation of the egg production amounts according to worm burden and length of Ascaris lumbricoides. Kor J Parasitol 19:38–44Google Scholar
  213. Chaia G, Cunha AS Da (1966) Terapeutica experimentel com o tiabendazol na estrongi- loidiase. Rev Inst Med Trop Sao Paulo 8:173–176PubMedGoogle Scholar
  214. Chaia G, Cunha AS Da (1971a) Therapeutic action of mebendazole (R 17 635) against human helminthiasis. Folha Med 63:67–76Google Scholar
  215. Chaia G, Cunha S Da (1971b) Therapeutic action of mebendazole (R 17635) against human helminthiasis. Folha Med 63:843–852Google Scholar
  216. Chaia G, Metene F, Chiari L, Araujo S de M, Abreu IB De (1972) Mebendazole — un novo antihelminthico de acao terapeutica polivalente. Folha Med 64:139–145Google Scholar
  217. Chanco PP, Atienza MR (1973) Trichuriasis - incidence, hazards and treatment with mebendazole (R 17 635). Preliminary report. Philipp J Microb Infect Dis 2:27–38Google Scholar
  218. Chanco PP, Paguio A (1964) Thiabendazole, a new broad spectrum anthelminthic. J Philipp Med Assoc 40:561—569Google Scholar
  219. Chanco PP, Tagama R (1965) Thiabendazole pamoate chewable tablets and plain thiabendazole chewable tablets. Int Med 3:33–40Google Scholar
  220. Chanco PP, Vidad JY (1978) A review of trichuriasis, its incidence, pathogenicity and treatment. Drugs [Suppl 1] 15:87–93Google Scholar
  221. Chanco PP, Vidad JY (1981) Review of trichiuriasis and its treatment with reference to the use of a single dose of oxantel/pyrantel suspension. Pfizer forum on common parasitic diseasesGoogle Scholar
  222. Chanco PP Jr, Talag-Padero J, Coo-Barcelona L, Vidad JY (1972) A new drug for the treatment of ancylostomiasis and necatoriasis: a preliminary report on Jonit. Asian J Med 8:152–157Google Scholar
  223. Chandra RK (1977) Nutritional deficiency and susceptibility to infection. Bull WHO 57:167–177Google Scholar
  224. Chandrasoma PT, Mendis KN (1977) Enterobius vermicularis in ectopic sites. Am J Trop Med Hyg 26:644–649PubMedGoogle Scholar
  225. Chappel LH (1980) Physiology of parasites. Blackie, GlasgowGoogle Scholar
  226. Chaptal J, Jean R, Labauge R, Bonnet H, Aghai E (1963) Myoclonies oppositionelles par intoxication ä la piperazine. Arch Fr Pediatr 20:17—23PubMedGoogle Scholar
  227. Chege SW, Gitoko F, Wanene GSN, Mwega VJ, Rees PH, Kinyanjui H (1974) Single dose treatment of hookworm in Meerang’a District. East Afr Med J 51:60–62PubMedGoogle Scholar
  228. Chernyshenko AI, Frolova AA, Chilikin MM, Bezuglov DA, Voevodina AI (1980) Com- bantrin effectiveness and tolerance in the mass treatment of enterobiasis, ascariasis, trichocephaliasis. Med Parazitol 49:66–68Google Scholar
  229. Chitanondh H, Rosen L (1960) Fatal eosinophilic encephalitis caused by the nematode Gnathostoma spinigerum. Am J Trop Med Hyg 16:638–645Google Scholar
  230. Chitrathorn S, Acalabol M, Thongkong M, Kamolsin C (1972) A single dose of phenylene- di-isothiocyanate (1,4) Jonit in the treatment of adult patients with hookworm infection in Sawan — pracharate hospital, Thailand. Southeast Asian. J Trop Med Public Health 3:103–105Google Scholar
  231. Chitwood MB, Velasquez C, Salazar NP (1964) Physiological changes in a species of Capillaria (Trichuroidea) causing a fatal case of human intestinal capillariasis. In: Proc int congress parasit. Roma, Sept 21–26, vol 2. Pergamon, Oxford, pp 797–798Google Scholar
  232. Chitwood MB, Velasquez C, Salazar NP (1968) Capillaria philippinensis sp.n. (Nematoda: Trichinellida) from the intestine of man in the Philippines. J Parasitol 54:368–371PubMedGoogle Scholar
  233. Cho SY (1976) Anthelminthic efficacy of combined preparation of pyrantel pamoate and oxantel pamoate on human intestinal nematodes. Kor J Pharmacol 12:69–73Google Scholar
  234. Cho SY (1977) Study on the quantitative evaluation of reinfection of Ascaris lumbricoides. Kor J Parasitol 15:17–29Google Scholar
  235. Cho SY (1980) A case of human anisakiasis in Korea. Seoul J Med 21:203–208Google Scholar
  236. Cho SY, Ahn Yo-R, Ryang Yo-S, Seo By-Se (1977) Evaluation of anthelminthic treatment on Enterobius vermicularis infection in a highly endemic population by prolonged observation. Kor J Parasitol 15:100–107Google Scholar
  237. Chobanov RE, Safieva LA, Sadykhov I A, Koleshichenko ML (1981) New data on Tricho- strongylus parasitism in man. Med Parazitol 50:17–18Google Scholar
  238. Chongsuphajaisiddhi T, Sabcharoen A, Attanath P, Panasoponkul C, Radomyos P (1978) Treatment of soil-transmitted nematode infections in children with mebendazole. Ann Trop Med Parasitol 72:59–63PubMedGoogle Scholar
  239. Chowdury AB (1971) Ascariasis — a health hazard. J Indian Med Assoc 57:294–296Google Scholar
  240. Chowdury AB (1972–1974) Open trial of mebendazole in Trichuris trichiura and hookworm infection. Janssen Pharmaceutica, Clin Res Report, N 5 722/N 8113Google Scholar
  241. Chowdury AB (1974) Clinical trials with mebendazole. Status Report, EthnorGoogle Scholar
  242. Chowdury AB, Bandyopadhyay AK, Banerjee M (1964) Preliminary observations on the clinical trial of thiabendazole against human helminthiasis. Bull Calcutta Sch Trop Med 12:124–125Google Scholar
  243. Chu WG, Chen PM, Huang CC, Hsu CT (1972) Neonatal ascariasis. J Pediatr 81:783–785PubMedGoogle Scholar
  244. Cimerman B, Pereira Fernandes M de F, Hernandes N, Campos Neto J, Campos Neto M (1980) Mebendazole — esquemas terapeuticos na practica clinica. Folha Med 4:80Google Scholar
  245. Cobbold R (1864) Entozoa: an introduction to the study of helminthology. Groombridge, LondonGoogle Scholar
  246. Cobbold R (1879) Parasites: a treatise on the entozoa of man and animals, including some account of entozoa. Churchill, LondonGoogle Scholar
  247. Coene A (1969) Rapport sur le traitement des helminthiases par le levo-tetramisole chez les malades hospitalisés à l’hôpital général de Bukavu. Janssen Pharmaceutica, Clin Res Rep N 522Google Scholar
  248. Colaert J (1976) Essai thérapeutique avec le flubendazole dans une école primaire à Kinshasa résultats préliminaires, remarques, critiques. Janssen Pharmaceutica, Clin Res Report N 11303Google Scholar
  249. Combescot Ch, Duong TH (1980) Action du fluoromebendazole (flubendazole) sur les helminthiases digestives. Méd Mal Infect 10:735–738Google Scholar
  250. Commey JOO, Haddock DRW (1970) Probable resistance to bephenium in Necator americanus infection. Ghana Med J 9:94–97Google Scholar
  251. Constazo S (1975) Evaluacion de un nuevo antiparasitario Mebendazol (R 17635). Prensa Med Argent 62:12–13Google Scholar
  252. Conte VP, Zaterka S, Costa FAB, Bettarello A (1974) Pirantel versus mebendazol no tratamento de ancilostomiase. Estudo comparetivo em 40 casos. Arq Gastoenterol 11:143–149Google Scholar
  253. Cornwell L, Jones RM (1968) Anthelmintic activity of pyrantel pamoate against Ancylostoma caninum in dogs. J Trop Med Hyg 71:165–166Google Scholar
  254. Correa MOA (1958) Estudo da açao terapeutica da thiazanina na estrongiloidose e na tricocefalose humana. Rev Inst Adolfo Lutz 18:123–131PubMedGoogle Scholar
  255. Correa MO A, Correa Fleury G, Lacerda Correo L De (1973) Terapeutica anthelminthica pelo levamisol em patientes pordadores de trichostrongilideos. Rev Inst Adolfo Lutz 33:45–47Google Scholar
  256. Cort WW, Stoll NR (1931) Studies on Ascaris lumbricoides and Trichuris trichiura in China. Am J Hyg 14:655–689Google Scholar
  257. Costa FV, Dos Santos CNR, Garcia CP de (1966) Contribucao as estudio comparativo de açao entre o hidroxinaftoato de befeno e o tetrachloretilenico. Açoa sobre a ancylostomiase e avaliaçao secundaria sobre a ascaridiase e tricocefaliase. Rev Bras Med 23:111—118PubMedGoogle Scholar
  258. Costanzo S (1975) Evaluacion de un nuevo antiparasitario, mebendazol (R 17635) Prensa Med Argent 62:12–13Google Scholar
  259. Coudert J, Garin JP, Battesti MR, Estienne J (1961) La dithiazanine, premier anthelminthique actif sur le trichocéphale. J Med Lyon 37:389–406Google Scholar
  260. Coulaud JP, Rossignol JF (1982) Albendazole: a new single dose anthelmintic. Study of 1,455 patients. Acta Trop 41:87–90Google Scholar
  261. Coulaud JP, Deluol AM, Cenac J, Rossignol JF (1982a) L’albendazole dans le traitement; de la strongyloidose. A propos de 66 observations. Bull Soc Pathol Exot Filiales 75:530–533PubMedGoogle Scholar
  262. Coulaud JP, Duchatelle C, Rouvillois A, Deluol AM (1982b) Le Zentel ® dans le traitement des helminthiases intestinales, au Niger, en Guinée et à Paris. Med Afr Noire 29:41–52Google Scholar
  263. Coutelen F, Biguet J, Capron A, Deblock S, Mine L (1956) Contrôle de l’action de quelques antihistaminiques dans le traitement de l’oxyurose. Thérapie 11:1119–1124PubMedGoogle Scholar
  264. Cram EB (1943) Studies on oxyuriasis XXVIII — Summary and conclusions. Am J Dis Child 65:46–59Google Scholar
  265. Croce JR, Campos V, Amato-Neto V, Dias De Avila Pires C, Campos Martins AC, Laurenti R, Mello e Albuquerque FJM (1963) Tratamento da estrongyloidiase pelo tiabendazol. Rev Inst Med Trop Sao Paulo 5:194–197PubMedGoogle Scholar
  266. Croll NA, Ghadirian E (1981) Wormy persons: contributions to the nature and patterns of overdispersion with A.lumbricoides, A. duodenale, N.Americanus and T.trichiura. Trop Geog Med 33:241–248Google Scholar
  267. Cross JH, Banzon TC, Clarke MD, Basaca-Servilla V, Watten RH, Dixon J (1972) Studies on experimental transmission of Capillaria philippinensis in monkeys. Trans R Soc Trop Med Hyg 66:819–827PubMedGoogle Scholar
  268. Cross JH, Banzon TC, Singson C (1978) Further studies on Capillaria philippinensis: development of the parasite in the Mongolian gerbil. J Parasitol 64:208–213PubMedGoogle Scholar
  269. Cross JH, Singson CN, Battad S, Basaca-Sevilla V (1980) Intestinal capillariasis: epidemiology, parasitology and treatment. In: Health policies in developing countries. Intern congress and symposium series. R Soc Medicine, London, pp 81–87Google Scholar
  270. Cruz Lopez A (1981) Estudio en poblacion abierta con albendazol. Sinp. latino americano Geohelminthiasis y albendazol. In: Compendium de invest clin Latino Americanas. Cancun, Mexico, pp 99–103Google Scholar
  271. Cruz Lopez O, Alcantrara R (1980) Estudio abierto de levamisole en el tratamiento de la ascariasis. Janssen Pharmaceutica, Clin Res Report, N 19199Google Scholar
  272. Cuckler AC (1961) Thiabendazole. J Parasitol [Suppl] 47:36–37Google Scholar
  273. Cuckler AC, Mezey KC (1966) The therapeutic efficacy of thiabendazole for helminthic infections in man. Arzneimittelforsch 16:411–428PubMedGoogle Scholar
  274. Cuckler AC, Egerton JR, Alicota JE (1965) Therapeutic effect of thiabendazole on Angiostiongylus cantonensis infections in rats. J Parasitol 51:392–396PubMedGoogle Scholar
  275. Da Cruz Ferreira FS, Cunha CAL Da, Guedes De Carvalho RF (1960) Ensaios terapéuticos com o „Bayer 2349” na ancilostomiase. An Inst Hig Med Trop 17:655–668Google Scholar
  276. Daensvang S (1968) Further observations on the experimental transmission of Gnathostomum spinigerum. Ann Trop Med Parasitol 62:88–94Google Scholar
  277. Dan V, Senghor G, Niang I (1973) Utilisation en médecine de masse des anthelminthiques (helminthes intestinaux). Med Afr Noire 20:997–1006Google Scholar
  278. Dancescu P, Toma L (1978) Some characters of a strain of Strongyloides stercoralis peculiar from Luzopa, sect CI, 6. ICOPAIV, WarsawaGoogle Scholar
  279. Danis M, Datry A, Meunier Y, Gentilini M (1980) Un nouvel anthelminthique à large spectre: le flubendazole. A propos de 125 observations. Gaz Méd Fr 87:5444–5446Google Scholar
  280. D’Antoni JS, Sawitz W (1941) The treatment of oxyuriasis. Am J Trop Med 20:377–383Google Scholar
  281. Da Silva G (1979) Flubendazole in the treatment of hookworm disease and trichuriasis: a dose range study. Janssen Pharmaceutica, Clin Res Report, N 18 075Google Scholar
  282. Da Silva JR, Courra LC, Carvalho HT de, Lopes PFD (1963) Tratamento do estrongili- diase. O Hospital 63:1247–1264PubMedGoogle Scholar
  283. Davis A (1973) Drug treatment in intestinal helminthiasis. World Health Organisation, GenevaGoogle Scholar
  284. Davis JH (1965) Thiabendazole in pinworm infestations. Am J Dis Child 109:567–570PubMedGoogle Scholar
  285. Davis JH (1966) Thiabendazole in pinworm infestations. Am J Dis Child 112:49–51PubMedGoogle Scholar
  286. Davis JH (1969) Pinworm infestations. Therapy with Thiabendazole. Tex Rep Biol Med [Suppl 2] 27:623–628Google Scholar
  287. Davis M J, Cilo M, Plaitakis A, Yahr MD (1976) Trichinosis: severe myopathic involvement with recovery. Neurology 26:37–40PubMedGoogle Scholar
  288. Davison RP (1979) Evaluation of mebendazole for the treatment of trichuriasis. Med J Aust 1:401–403PubMedGoogle Scholar
  289. Degremont A, Baumgartner MW (1975) Le traitement des helminthiases intestinales au mebendazole: a propos de 294 patients traités. Schweiz Med Wochenschr 105:1830–1832PubMedGoogle Scholar
  290. Degremont A, Stahel E (1978) Klinische Bewertung von Ciclobendazol (C-C 2481) bei der Behandlung von Wurmerkrankungen des Darmes. Schweiz Med Wochenschr 108:1430–1433PubMedGoogle Scholar
  291. De Jonckheere U (1975) Single oral doses of levamisole in the treatment of ascariasis. Janssen Pharmaceutica, Clin Res Report, R 12 564/26, N 9707Google Scholar
  292. Derne J, Sagnet H (1961) Traitement de l’ankylostomose par l’hydroxynaphtoate de béphenium. Méd Trop 21:393–395Google Scholar
  293. Demoen P, Aelst C Van, Loomans J, Verhaegen H, Cree J De, Verbruggen F, Ringoir S (1973) The absorption and urinary excretion of mebendazole after oral administration. Janssen Pharmaceutica, Clin Res Report, R 17 635/36Google Scholar
  294. De Oliveira Gomez MC (1974) Tratamento das parasitoses intestinais com mebendazole suspensao. Folha Med 68:541–543Google Scholar
  295. De Oliveira Gomez MC (1977) Tratamento da estrongiloidiase pelo cambendazole. Folha Med 74:535–537Google Scholar
  296. De Oliveira Gomez MC (1979) Flubendazole in the treatment of trichiuriasis: a dose range study. Janssen Pharmaceutica, Clin Res Report, N 17 495Google Scholar
  297. De Oliveira Gomez MC, Zangari CLM (1979) Treatment of intestinal parasitosis with flubendazole. Janssen Pharmaceutica Clin Res Report N 21273Google Scholar
  298. De Oliveira MC, Souza DWC De, Castro A De, Neves J (1971) O tetramisole levogiro na terapeutica da ascaridiase. Folha Med 62:59–63Google Scholar
  299. De Paulo Castro L, Pereira Rezende H, Carvalho MF De (1970) Tratamento de ascaridiase com o levamisole. Analise de 200 casos. Rev da Assoc Med de Minas Gérais 21:165–167Google Scholar
  300. De Paulo Castro L, Pereira Rezende H, Carvalho MF De, Horizonte B (1971) Estudo Comparativo, pelo metodo duple-cego, entre o’tetramisole’ e o ’levamisole’ na terapeutica da ascaridiase. Rev Assoc Med Brasil 17:237–240Google Scholar
  301. De Paulo Castro L, Cunha SA Da, Ribeiro de CT, Resende PH (1973) Estudo farmaco- clinico e terapeutico de un novo anti-helmintico, o mebendazole (R 17635), em crian- cas poliparasitadas. Rev Assoc Med Brasil 19:441–446Google Scholar
  302. De Saedeleer G (1975) Mebendazole, traitement efficace de la trichocéphalose. Louvain Med 94:41–48Google Scholar
  303. Desai AS (1962) Single dose treatment of oxyuriasis with pyrvinium embónate. Br Med J 2:1583–1585PubMedGoogle Scholar
  304. Deschiens R (1943) Sur les propriétés anthelminthiques des dérivés du triphénylméthane. CR Séances Acad Sci 217:513–515Google Scholar
  305. Deschiens R (1946) L’action anthelminthique de la phénothiazine (Thiodiphenylamine) et de ses dérivés. Presse Méd 54:53–54PubMedGoogle Scholar
  306. Deschiens R, Benex J (1957) Essais experimentaux et cliniques de traitement de l’anguillulose intestinale par le sousnitrate et par le carbonate de bismuth. Bull Soc Pathol Exot Filiales 50:70–74PubMedGoogle Scholar
  307. Deschiens R, Poirier M, Lamy L (1954) Sur l’action anthelminthique des dérivés de l’ethy- lenediamine et de la piperazine. Bull Soc Pathol Exot Filiales 47:83–86PubMedGoogle Scholar
  308. De Souza DWC, Neves J, Lemos MS De (1972) Estudo comparativo entre a efficacia terapeutica do pamoate de pirantel e do levamisole na ascaridiase. Rev Inst Med Trop Sao Paulo 14:67–72PubMedGoogle Scholar
  309. De Souza CDW, Lemos Souza MS De, Neves J (1973a) Açao terapeutica do mebendazole (R 17635) em pacientes poliparestidaos. Resultados preliminares. Rev Inst Med Trop Sao Paulo 15:30–35PubMedGoogle Scholar
  310. De Souza DW, Lemos Souza S De, Neves J (1973b) Açao terapeutica do mebendazole (R 17635) em patientes poliparasitados. Resultados fináis. Rev Soc Brasil Med 7:237—241Google Scholar
  311. Desowitz RS, Bell Th, Williams J, Cardines R, Tamarua M (1970) Anthelminthic activity of pyrantel pamoate. Am J Trop Med Hyg 19:775–778PubMedGoogle Scholar
  312. Dessakorn V (1980) Clinical field trial of flubendazole on hookworm, Trichuris and Ascaris infection. Janssen Pharmaceutica, Clin Res Report, N 17449Google Scholar
  313. Detels R, Gutman L, Jaramillo J, Zerrudo E, Banzon T, Valera J, Murrell KD, Cross J, Dizon JJ (1969) An epidemic of intestinal capillariasis in man. Am J Trop Med Hyg 18:676–682PubMedGoogle Scholar
  314. De Wulf MD (1975) Flubendazole in the treatment of enterobiasis: a double-blind placebo- controlled study. Janssen Pharmaceutica, Clin Res Report, R 17 889/5Google Scholar
  315. Digues La Tonche DM (1962) Bephenium compared with tetrachlorethylene in mass treatment of hookworm. J Trop Med Hyg 65:107–111Google Scholar
  316. Dissanaike AS (1978) A comparative trial of oxantel-pyrantel and mebendazole in multiple helminth infection in school children. Drugs [Suppl] 15:11–15Google Scholar
  317. Dizon JJ, Watten RH (1969) Preliminary observations on a new disease in man: intestinal capillariasis. J Philippine Med Assoc 45:5–20Google Scholar
  318. Domart A, Gentilini M, Therizol M, Carbon C (1967) Traitement de la strongyloidose par le thiabendazole (à propos de 100 cas). Bull MémSocMéd Hop 118:1047–1050Google Scholar
  319. Do Nascimento OB, Halsman M, Oria H, Martins Campos JV (1966) Clinical study of the therapeutic value of single oral doses of a new anthelminthic tetramisole (R 8 299) against ascariasis. Rev Inst Med Trop Sao Paulo 8:143–147Google Scholar
  320. Donoso F, Atias A (1961) Tratamiento de la oxyuriosis con pamoate de la pyrvinium pamoate (Poquil). Bol Chil Parasitol 16:88–90Google Scholar
  321. Doshi JC, Vaidya AB, Sen HG, Mankodi NA, Nair CN, Greural RS (1977) Clinical trials of a new anthelmintic 4-isothiocyanato-4-nitrodiphenylamine for the cure of hookworm infection. Am J Trop Med Hyg 26:636–639PubMedGoogle Scholar
  322. Dudley BW, Lease EJ (1973) Intestinal helminths in children in coastal South Carolina: follow-up report. South Med J 66:1100PubMedGoogle Scholar
  323. Dürr JM (1969) Résultats des essais thérapeutiques du dérivé levogyre du tetramisole dans les helminthiases humaines. Thèse, ParisGoogle Scholar
  324. Dufek M, Kalivoda R (1973a) Levamizol a mebendazol — nova anthelmintika. Cas Lek Cesk 112:633PubMedGoogle Scholar
  325. Dufek M, Kalidova R (1973b) Treatment of intestinal parasitic infections with levamisole and mebendazole. Bull Inst Marit Med Gdansk 24:325–327Google Scholar
  326. Dutta JK (1970) Treatment of ankylostomiasis with combined therapy of bephenium hydroxynaphtoate and tetrachlorethylene. J Indian Med Assoc 54:150—152PubMedGoogle Scholar
  327. Egerton JR, Campell WC (1970) The efficacy of 5-isopropoxycarbonylamino-2-(4- thiazolyl)-benzimidazole against helminths in sheep. Res Vet Sci 11:193–195PubMedGoogle Scholar
  328. Eliachar E, Pavlotski D, Tassy R (1960) Incidents neurologiques après l’utilisation de piperazine comme vermifuge. Arch Fr Pédiatr 17:797–803PubMedGoogle Scholar
  329. El-Mosry NA, Trabolsi B, Bassily S, Farid Z (1983) Albendazole in the treatment of Ancylostoma duodenale and Ascaris lumbricoides infections. Trans R Soc Trop Med Hyg 77:160–161Google Scholar
  330. Ericksen V (1964) Treatment of oxyuriasis with pyrvinpamoate. Acta Paediatr 53:489–491Google Scholar
  331. Escobar AJJ (1964) Tiabendazol, un nuevo antihelmintico de amplio espectro. Antioquia Med 14:369–387Google Scholar
  332. Evdokimov V, Ntibarutaye J (1970) Ascaridiose et son traitement par levo-tetramisole (Decaris) au Burundi. Rev Méd Burundi 2:15–21Google Scholar
  333. Excler JL, Mojon M, Petavy AF, Cadi-Soussi M (1981) Foyer d’ankylostomiase dans une plantation de jasmin. Essai thérapeutique par l’albendazole, mené en double aveugle. Bull Soc Pathol Exot Filiales 75:349–355Google Scholar
  334. Farahmandian I, Sahba GH, Sadeghi E (1971) Prevalence of helminthiasis in a village of the derful area and comparison of therapeutic effect of alcopar and mintezol. J Gen Med Teheran Univ 9:305–307Google Scholar
  335. Farahmandian J, Sahba GH, Arfar F, Jabali H (1972) A comparative evaluation of the therapeutic effect of pyrantel pamoate and bephenium hydroxynaphtoate on Ancylos- toma duodenale and other intestinal helminths. J Trop Med Hyg 75:205–207PubMedGoogle Scholar
  336. Farahmandian I, Arfaa F, Sahba GH, Jalali H (1974) Preliminary trial on the effect of laevo-tetramisole on various intestinal helminthiases in Iran. Iran J Public Health 3:92–96Google Scholar
  337. Farahmandian I, Arfaa F, Jalali H, Reza M (1977) Comparative studies on the evaluation of the effects of new antihelminthics on various helminthiases in Iran. Chemotherapy 23:98–105PubMedGoogle Scholar
  338. Farid Z (1963) Treatment of oxyuriasis. Br Med J 1:330PubMedGoogle Scholar
  339. Farid Z (1964) Treatment of multiple helminthic infections in Egypt with dithiazanine. J Trop Med Hyg 67:200–203PubMedGoogle Scholar
  340. Farid Z, Miale A Jr (1962) Treatment of hookworm infection in Egypt with bephenium hydroxynaphtoate and the relationship between iron deficiency, anemia and intensity of infection. Am J Trop Med Hyg 11:497–505PubMedGoogle Scholar
  341. Farid Z, Bassily S, Wissa J, Omar MS (1966) Single-dose treatment for ascaris infection with piperazine citrate, with a study of the egg-parasite ratio. Am J Trop Med Hyg 15:516–519PubMedGoogle Scholar
  342. Farid Z, Bassily S, Young SW, Hassan A (1973) Tetramisole in the treatment of Ancylostoma duodenale and Ascaris lumbricoides infections in Egyptian farmers. Trans R Soc Trop Med Hyg 67:425–426PubMedGoogle Scholar
  343. Farid Z, Bassily S, Miner WF, Hassan A, Laughlin AW (1977) Comparative single dose treatment of hookworm and roundworm infections with levamisole, pyrantel and bephenium. J Trop Med Hyg 80:107–108PubMedGoogle Scholar
  344. Fayard C (1949) Ascaridase et piperazine. Thèse Méd., no. 889, ParisGoogle Scholar
  345. Feldmeyer H, Bienzle U, Dômring E, Dietrich M (1982) Flubendazole versus mebendazole in intestinal helminthic infections. Acta Trop 39:185–189Google Scholar
  346. Feng DCH, Mao SH-G, Liv ERHS (1960) Research on parasitic diseases in new China. Chin Med J 80:1–20PubMedGoogle Scholar
  347. Fernandes JL, Garcia E (1976) Atividade terapéutica da associaçao piperazina-tiaben- dazol em escolares portodores des verminose. Rev Soc Bras Med Trop 5:155–158Google Scholar
  348. Fernandes P (1974) A importenzia do mebendazole no combate as helmintiases das popu- lacoes rurais. Folha Med 69:301–302Google Scholar
  349. Fernandez Ortega F (1982) Albendazol a dosis única, en parasitosis indestinales en ninos. Informe de 100 cases. Invest Med Int (Mexico) 9:124–126Google Scholar
  350. Fernando MA, Balasuriya S (1977) Control of Ascariasis by mass treatment with piperazine citrate. Ceylon Med J 22:120–128PubMedGoogle Scholar
  351. Ferreira FSC da, Cunha CAL Da, Carvalho RF (1960) Ensaios terapéuticos com o Bayer 2349 na ancilostomiase. An Inst Hig Med Trop 17:655–668Google Scholar
  352. Fierlafijn E (1971) L’oxyurose: traitement ancien et actuel. Brux Méd 51:605–608PubMedGoogle Scholar
  353. Fierlafijn E, Parijs OF Van (1973) Mebendazole in enterobiasis. Trop Geogr Med 25:242–244PubMedGoogle Scholar
  354. Figuerredo-Mendes T, Fonesca EE, Guedes R, Salun N, Garrido I (1962) Treatment of penitentiary inmates for intestinal parasites in Rio de Janeiro. Am J Trop Med Hyg 11:631–632Google Scholar
  355. Filho FF, Duarté GG, Teruel JR, Franco AR (1971) Estudo de uma attociaçâs antihelmíntica em parasitoses intestinais múltiplas. Rev Soc Bras Med Trop 5:209–212Google Scholar
  356. Fleury Correa G, Correa AMO, Amato-Neto V (1970) Identificacao do Trichostrongylus colubriformis coma parasita do homem. Rev Inst Med Trop Sao Paulo 12:288–292Google Scholar
  357. Foba-Pagou R, Carrie J, Ripert C (1978) Traitement des helminthiases humaines: teniase, ascaridose, necatorose, trichocephalose, strongyloidose par le mébendazole. 12e Conf techn OCEAC, YaoundeGoogle Scholar
  358. Forrester ATT, Nelson GS, Sander G (1961) The first record of an outbreak of trichinosis in Africa south of the Sahara. Trans R Soc Trop Med Hyg 55:503–513PubMedGoogle Scholar
  359. Franz KH (1963) Clinical trials with thiabendazole against human strongyloidiasis. Am J Trop Med Hyg 12:211–214Google Scholar
  360. Franz KH (1965) Clinical trials with thiabendazole against intestinal nematodes infecting humans. Am J Trop Med Hyg 14:383–386PubMedGoogle Scholar
  361. Franz KH, Schneider WJ, Pohlman MH (1965) Clinical trials with thiabendazole against intestinal nematodes infecting humans. Am J Trop Med Hyg 14:383–386PubMedGoogle Scholar
  362. Freire DA, Oetting GA Jr, Freire EM, Ruano AC, Amato Neto V (1969) Tratamento da ascaridiase por meio do levamisole-base. O Hospital 76:1715–1719PubMedGoogle Scholar
  363. Fritz L (1965) Ein Beitrag zur Ein-Dosis Behandlung der Oxyuris vermicularis mit pyrvinium pamoate. Wien Med Wochenschr 115:122–124PubMedGoogle Scholar
  364. Fry GF, Moore JG (1969) Enterobius vermicularis: 10,000-year-old human infection. Science 166:1620PubMedGoogle Scholar
  365. Frye WW, Swartzwelder C, Lampert R, Abadie SH, Carson CB (1957) An effective trichuricide suitable for oral administration. Am J Trop Med Hyg 6:890–893PubMedGoogle Scholar
  366. Gaitonde BB, Kamat RA, Kulkarni H J, Vakil BJ (1969) Clinical evaluation of a new anthelminthic; phenylene diisothyocyanate (bitoscanate) in hookworm and roundworm infestation. J Trop Med Hyg 72:253–258PubMedGoogle Scholar
  367. Gamboa JA, Eduarte CA, Marin RM, Migliardi JR, Villarejos VM (1969) Pyrantel Pamoate: un nueva antihelminthico. 37th congresso med nac de San Jose, November 1969, Costa RicaGoogle Scholar
  368. Garcia EG (1976) Treatment of trichuriasis with oxantel. Am J Trop Med Hyg 25:914–915PubMedGoogle Scholar
  369. Garcia EG (1978) Treatment of multiple intestinal helminthiasis with oxantel and pyrantel. Drugs [Suppl 1] 15:70–72Google Scholar
  370. Garin JP (1962) Traitement de l’oxyurose de l’enfant de moins de 10 ans par une dose unique d’embonate de pyrvinium (Povanyl). Pédiatrie 17:551–552PubMedGoogle Scholar
  371. Garin JP (1980) L’Albendazole dans l’oxyurose. Int Clin Res Report Smith Kline French, Lyon, FranceGoogle Scholar
  372. Garin JP (1981) L’Albendazole dans la trichocéphalose et dans l’ankylostomose. Int Clin Res Rep Smith Kline FrenchGoogle Scholar
  373. Garin JP, Mojon M (1980) Albendazole in the treatment of intestinal helminthiasis. A double blind controlled multicenter clinical trial. Congress, Marseille, November 1980Google Scholar
  374. Garin JP, Despeigne J, Tasseau M (1965) L’Anguillulose et son traitement. J Med Lyon 46:1071–1088PubMedGoogle Scholar
  375. Garin JP, Despeignes J, Woehrle R, Ambroise-Thomas P (1970) La diphetarsone, médicament actuel de la trichocephalose. Bull Soc Pathol Exot Filiales 63:94–100PubMedGoogle Scholar
  376. Garin JP, Mojon M, Piens MA, Rossignol JF (1980a) Albendazole efficacy on a long term follow up in patients with intestinal helminthiasis. In: 10th international congress of tropic medicine malaria, Manila, abstract 235. Printing, Quezon City, p 148Google Scholar
  377. Garin JP, Mojon M, Piens MA, Rossignol JF (1980 b) Albendazole in the treatment of intestinal helminthiasis: a Euro-African double blind controlled multicenter clinical trial. In: 10th Int congress trop med malaria, Manila, abstract 236. Printing Quezon City, p 148Google Scholar
  378. Gatherer A (1977) The prevalence, diagnosis and treatment of threadworm infestation. Practioner 219:871–875Google Scholar
  379. Gatti F, Vandepitte J (1973) The efficacy of various dosages of mebendazole for the treatment of major intestinal roundworm parasites. Janssen Pharmaceutica, Clin Res Report,N 7 320Google Scholar
  380. Gatti F, Vanderick F, Parent M, Bulihereme S, Vandepitte J (1969) Treatment of roundworm infection in African children with a single dose of tetramisole (R 8299). Ann Soc Belg Méd Trop 49:51–62Google Scholar
  381. Gatti F, Krubwa F, Vandepitte J, Thienpont D (1970) Antinematodal effect of the trimes- trial administration of a single dose of levamisole to Congolese schoolchildren. 5th intern congress infect diseases, Aug 31-Sept 5 1970, ViennaGoogle Scholar
  382. Gatti F, Krubwa F, Vandepitte J, Thienpont D (1972a) Control of intestinal nematodes in African schoolchildren by the trimestrial administration of levamisole. Ann Soc Belg Méd Trop 52:19–32PubMedGoogle Scholar
  383. Gatti F, Krubwa F, Lontie M, Vandepitte J, Thienpont D (1972 b) Clinical experience with mebendazole, a new broad-spectrum anthelminthic. Advances in antimicrobial and antineoplastic chemotherapy. Urban, SchwarzenbergGoogle Scholar
  384. Gelpi MC, Mustafa A (1967) Seasonal pneumonitis with eosinophilia. A study of larval ascariasis in Saudi Arabia. Am J Trop Med Hyg 16:646–657PubMedGoogle Scholar
  385. Gelpi MC, Mustafa A (1968) Ascaris pneumonia. Am J Med 44:377–389PubMedGoogle Scholar
  386. Gentilini M (1974) Expertise clinique du mebendazol. Janssen Pharmaceutica, Clin Res Report N 8 247Google Scholar
  387. Gentilini M (1976) Expertise clinique - flubendazole comprimés. Janssen Pharmaceutics, Clin Res Report N 12 250Google Scholar
  388. Gentilini M, Robineau M, Durr JM, Domart A (1970) Résultats des essais thérapeutiques dans les helminthiases traitées par le L-tetramisole. Bull Soc Pathol Exot Filiales 63:52- 61Google Scholar
  389. Gentilini M, Danis M, Dürr JM, Garabiol B (1971) Traitement de l’ankylostomiase par l’association thiabendazole-lévamisol. Bull Soc Pathol Exot Filiales 64:891–900PubMedGoogle Scholar
  390. Gentilini M, Danis M, Dournovo P (1976) Activité et tolerance du pamoate de pyrantel dans les nématodoses intestinales. La Vie Médicale 10:603–604Google Scholar
  391. Ghadirian E (1978) Human infection with Trichostrongylus lerouxi in Iran. Am J Trop Med Hyg 26:1212–1213Google Scholar
  392. Ghadirian E, Arfaa F (1975) Present status of trichostrongyliasis in Iran. Am J Trop Med Hyg 24:935–941PubMedGoogle Scholar
  393. Ghadirian E, Sanati A (1972) Preliminary studies on the treatment of hookworm with pyrantel pamoate in Iran. J Trop Med Hyg 75:199–201PubMedGoogle Scholar
  394. Ghadirian E, Sanati A, Misaghian G, Yossefi A (1972) Treatment of ascariasis with pyrantel pamoate in Iran. J Trop Med Hyg 75:195–197PubMedGoogle Scholar
  395. Ghyssels G, Sartiaux P (1959) Le traitement de l’ankylostomiase par l’hydroxynaphtoate de bephenium. Ann Soc Belg Méd Trop 39:637–642Google Scholar
  396. Goeters W (1955a) Die Behandlung der Oxyuriasis mit Terramycin (Oxytetracyclin). Arzneimittelforsch 5:517–519PubMedGoogle Scholar
  397. Goeters W (1955b) Zur Behandlung der Oxyuriasis im Kindesalter. Dtsch Med Wo- chenschr 80:312–313PubMedGoogle Scholar
  398. Goldsmid JM (1972a) Tiabendazole in the treatment of human infections with Ternidens deminutus (nematoda). S Afr Med J 46:1046–1047PubMedGoogle Scholar
  399. Goldsmid JM (1972b) Ternidens deminutus and hookworm in Rhodesia and a review of the treatment of human infections with T. deminutus. Cent Afr J Med [Suppl] 18:1–14Google Scholar
  400. Goldsmid JM (1973) The use of mebendazole as a broad spectrum anthelminthic in Rhodesia. S Afr Med J 48:2265–2266Google Scholar
  401. Goldsmid JM (1974) The use of mebendazole as a broad spectrum anthelminthic in Rhodesia. S Afr Med J 48:2265–2266PubMedGoogle Scholar
  402. Goldsmid JM, MacCabe RJ (1972) Preliminary studies on the use of phenylene-di-isothio- cyanete (1,4) in the treatment of hookworm and Ternidens deminutus infections in Rhodesia. Cent Afr J Med 18:227–229PubMedGoogle Scholar
  403. Goldsmid JM, Saunders CR (1972) Preliminary trial using pyrantel pamoate for the treatment of human infections with Ternidens deminutus. Trans R Soc Trop Med Hyg 66:375PubMedGoogle Scholar
  404. Goldsmid JM, Saunders RC (1973) Pyrantel pamoate for human hookworm infection. S Afr Med J 47:25–26Google Scholar
  405. Gomez-Ferrar W (1963) Tratamento da estrongiloidiase e da ascaridiase com thiabenazol. O Hospital 64:1381–1388Google Scholar
  406. Goodwin LG, Standen OD (1954) Treatment of roundworm with piperazine citrate Ante-par. Br Med J 2:1332–1333Google Scholar
  407. Goodwin LG, Standen OD (1958) Treatment of ascariasis with various salts of piperazine. Br Med J 1:131PubMedGoogle Scholar
  408. Goodwin LG, Jayewardene LG, Standen OD (1958) Clinical trials with bephenium hy- droxynaphtoate (“Alcopar”) against hookworm in Ceylon. Br Med J 2:1572–1576PubMedGoogle Scholar
  409. Gordon JA, Ross CM, Affleck H (1969) Abdominal emergency due to an oesophagostome. Ann Trop Med Parasitol 63:161–164PubMedGoogle Scholar
  410. Gorodner JO, Gorodner AM, Navarro E (1977) Accion therapeutica del mebendazole (R 17 635) en uncinariasis y enterobiasis. Medicina 37:389–392Google Scholar
  411. Gould SE (1945) Trichinosis in man and animals. Thomas, Springfield Gould SE (1971) The tory of trichinosis. Am J Clin Pathol 55:2–11Google Scholar
  412. Graham CF (1941) A device for diagnosis of Enterobius infection. Am J Hyg 21:159–161Google Scholar
  413. Grove DI (1982) Treatment of strongyloidiasis with thiabendazole: an analysis of toxicity and effectiveness. Trans R Soc Trop Med Hyg 76:114–118PubMedGoogle Scholar
  414. Guarniera D, Leonardi G, Ceccarelli G (1969) Pyrantel pamoate in the therapy of infestations from E. vermicularis. Ped IntGoogle Scholar
  415. Guerrero L, Holguin J, Botero D (1960) The use of dithiazanine as a mass treatment for intestinal helminthiasis. Am J Trop Med Hyg 9:37–38PubMedGoogle Scholar
  416. Guggenmoos R, Akhtaruzzaman KM, Rosenkaimer F, Gaus W, Bienzle U, Dietrich M (1978) Comparative trial of therapeutic effectiveness of the new anthelminthic drug: ci- clobendazole. Tropenmed Parasitol 29:423–426PubMedGoogle Scholar
  417. Guilhon J (1977) Origine des récentes épidemies de trichinose humaine observées en France. Bull Acad Natl Méd 161:174–178Google Scholar
  418. Guimaraes JX, Ferraz WPG, Adura M, Villela M de P, Pucei H, Soares MA, Lopes ER (1961) O emprego do iodeto de ditiazanina na estrongiloidose. Rev Paul Med 58:389- 394Google Scholar
  419. Guimaraes VMA, Penha Sobrinho OA, Marcondes Silva C (1971) O levamisole na trat- mento da ascaridiase en pacientes internados. Folha Med 63:129—134Google Scholar
  420. Guiness Book of Records (1977) Guiness Superlatives, LondonGoogle Scholar
  421. Gunders AE (1962) Dithiazanine in the treatment of intestinal nematodes. Parasite infections in the tropics. West Afr Med J 11:74–76PubMedGoogle Scholar
  422. Gupta MC, Basu AK, Tandon BN (1974) Gastrointestinal protein loss in hookworm and roundworm infections. Am J Clin Nutr 27:1386–1389PubMedGoogle Scholar
  423. Gupta MC, Mithal S, Tandon BN (1976) Use of tetramisole for mass deworming in a community with heavy Ascaris infection. J Indian Med Assoc 67:180–182PubMedGoogle Scholar
  424. Gupta MC, Mithal S, Arora KL, Tandon BN (1977) Effect of periodic deworming on utritional status of ascaris-infected preschool children receiving supplementary food. Lancet 2:108–110PubMedGoogle Scholar
  425. Gupta PS, Gambhir DS, Oswal S, Kumar N (1979) 4-nitro-4-isothiocyanediphenylamin. A new anthelmintic in hookworm infestation. J Trop Med Hyg 82:117–119Google Scholar
  426. Haaf E, Soest AH Van (1964) Oesophagostomiasis in man in North Ghana. Trop Geogr Med 16:49–53PubMedGoogle Scholar
  427. Hahn SS, Kang HY, Hahn YS (1960) The anthelminthic effect of bephenium hy- droxynaphtoate on intestinal helminths. J Trop Med Hyg 63:180–184Google Scholar
  428. Haleem MA, Lari FA, Rahimtoola RJ (1971) Comparative efficacy and toxicity of pyrantel pamoate and piperazine citrate in paediatric ascariasis. J Pakist Med Assoc 22:276–282Google Scholar
  429. Hall MC (1921) Carbon tetrachloride for the removal of parasitic worms, especially hookworms. J Agric Res 21:157–175Google Scholar
  430. Hall MC, Shillinger J (1925) Tetrachlorethylene, a new anthelminthic. Am J Trop Med 5:229–237Google Scholar
  431. Hall SA, Joseph MM, Saggar SN, Wood CH, Gleisner E (1970) A trial of ketrax (the laevo- isomer of tetramisole) in the treatment of ascariasis. East Afr Med J 47:424—433PubMedGoogle Scholar
  432. Hanna M, Shehata A (1955) Treatment of ascariasis in children with piperazine adipate. Br Med J 2:417–418PubMedGoogle Scholar
  433. Harada Y, Mori O (1953) A new method for culturing hookworm. Yonago Act Med 1:177—179 [in: Trop Dis Bull 53:343 (1956)]Google Scholar
  434. Harfouche JK, Abi-Yaghi M J, Karam M, Isawi F (1974) Single oral dose of combantrin (pyrantel pamoate) in the treatment of enterobiasis and ascariasis. Leban Med J 27;159–168Google Scholar
  435. Hartz PH (1953) Histopathology of the colon in massive trichocephaliasis in children. Doc Med Geogr Trop 5:303–323PubMedGoogle Scholar
  436. Harwood PD, Jerstad AC, Swanson LE (1938) The efficacy of phenothiazine for removal of ascarids from swine. J Parasitol [Suppl] 24:16–17Google Scholar
  437. Hatchuel W, Isaacson M, Villiers DJ De (1973) Pyrantel pamoate in round worm infestation. A comparative trial with piperazine citrate given in a single dose. S Afr Med J 47:91–93PubMedGoogle Scholar
  438. Hayashi S (1980) A model for the evaluation and assessment of the effect of control of soil transmitted helminthiases. In: Collected papers on the control of soil-transmitted helminthiases. Asian Parasite Control Organization 1:265–273Google Scholar
  439. Hayashi S, Wakai R, Motoyoshi K, Mori Y, Isozaki A (1976) The efficacy of a newly developed tablet of pyrvinium pamoate against pinworm. Jpn J Parasit 25:100–108 (in Japanese)Google Scholar
  440. Hewitt RI, White E, Wallace WS, Stewart HW, Kushner S, Subba Row Y (1947) Experimental chemotherapy of filariasis. II. Effect of piperazine derivatives against naturally acquired filarial infections in cotton rats and dogs. J Lab Clin Med 32:1304—1313PubMedGoogle Scholar
  441. Hewitt R, Wyeth W, White E, Subrarow Y (1948) The treatment of ascariasis in dogs with l-diethyl-carbamyl-4 methylpiperazine hydrochloride. J Parasitol 34:237–239PubMedGoogle Scholar
  442. Hoekenga MT (1955) Treatment of multiple intestinal worm infections with piperazine citrate. Am J Trop Med Hyg 4:1088–1090PubMedGoogle Scholar
  443. Hoeppli R (1959) Parasites and parasitic infections in early medcine and science. UniversityGoogle Scholar
  444. of Malaya Press, SingaporeGoogle Scholar
  445. Hoff DR, Fisher MH, Bochis BJ, Lusi A, Waksmunski F, Egerton JR, Yakstis JJ, Cuckler AC, Campell WC (1970) A new broad-spectrum anthelminthic 2-(4-thiazolil)-5-isopro- pylcarbonylamino-benzimidazole. Experientia 26:550–551PubMedGoogle Scholar
  446. Holtz J, Adhman D, Gunardi AT, Murat S, Sadeli OR, Wuisan JO (1972) A single dose of Jonit in the treatment of human ancylostomiasis. Southeast J Trop Med Public Health 3:99–102Google Scholar
  447. Howes HL Jr (1972) Trans-l,4,5,6-tetrahydro-2-(3-hydroxystyryl)-l- methyl pyrimidine (CP-14445) a new antiwhipworm agent. Proc Soc Exp Biol Med 139:394–398PubMedGoogle Scholar
  448. Howes HL, Lynch JE (1967) Anthelmintic studies with pyrantel; therapeutic and prophylactic efficacy against the enteral stages of various helminths in mice and dogs. J Parasitol 53:1085–1091PubMedGoogle Scholar
  449. Howie VM (1955) Ten-day treatment of pinworm infection with piperazine. Am J Child Dis 89:202–203Google Scholar
  450. Hsieh Hs-Ch, Chen EN-R (1970) Evaluation of anthelmintic activity of pyrantel pamoate (Combantrin) against Ascaris and hookworm. Chin J Microb 3:126–130Google Scholar
  451. Hsieh HC, Chow LP, Shih CC (1960 a) Mass treatment of hookworm infections with te- trachlorethylene and 1-bromo-naphtol 2 at two rural villages in southern Taiwan. J Formosan Med Assoc 59:53–59Google Scholar
  452. Hsieh HC, Brown HW, Fite M, Chow LP, Cheng CS, Hsu CC (1960 b) The treatment of hookworm, Ascaris and Trichuris infections with bephenium hydroxynaphtoate. Am J Trop Med Hyg 9:496–499Google Scholar
  453. Hsieh HC, Kuo M, Chow LP, Cheng CS, Chen CY, Chang CR (1961) A combined dose of bephenium hydroxynaphtoate and tetrachlorethylene against mixed infection of A. duodenale and N. americanus. J Formosan Med Assoc 60:926–936Google Scholar
  454. Hsieh HC, Brown HW, Chen ER, Chen CY, Shih CC (1963) Treatment of Fasciolopsis buski, Ancylostoma duodenale, Ascaris lumbricoides, Trichuris trichiura and Enter obius vermicularis infections with stilbazium iodide. J Parasitol 49:425–427Google Scholar
  455. Hsieh Hs-Ch, Chen Ch-Y, Yi CH-Y, Chen M-Hs, Hong J-M (1970) The therapeutic efficacy of phenylene-di-isothiocyanate (1,4) against A. duodenale and N. americanus in Taiwan. Chi J Microbiol 69:13–17Google Scholar
  456. Hsieh Hs-Ch, Chen EN-R, Shih CC (1971) Treatment of Enter obius vermicularis infections with pyrantel pamoate in Taiwan. Chin J Microbiol 4:247–253Google Scholar
  457. Huang WH, Brown HW (1963) The efficacy of thiabendazole against hookworm and ascariasis in man. J Parasitol 49:1014–1018PubMedGoogle Scholar
  458. Huang WH, Brown HW (1964) Clinical trials of stilbazium iodide (Monopar) in the treatment of Trichuris and Ascaris infections. Am J Trop Med Hyg 13:54—56PubMedGoogle Scholar
  459. Hudson B (1976) Clinical summary: phase IV study-Vermox-Ortho Aug. Clin Res Rep Or- tho Pharmaceutical Corporation, RD, Raritan, New Jersey 08869Google Scholar
  460. Huggins D (1970) Ensaio terapeutico com o levamisole (composto R 8299) na ascariase. O Hospital 78:247–251Google Scholar
  461. Huggins DW (1976) Ensaio clinico com mebendazole no tratamento das helminthiases in- testinais. IV congr. Latino Americano de parasitologia, San Jose. D. A. 10, p 121Google Scholar
  462. Huggins D (1977–1978) Terapeutica das helmintiases intestinais com an nova associaçao medicamentosa: cambendazol+mebendazol. An Inst Hig Med Trop 5:409–419Google Scholar
  463. Huggins DW (1979a) Ensaio clinico com nova Associaçao: tinidazol+flubendazol, para o tratamento das enteroparasitoses. Rev Bras Med 36:581–583Google Scholar
  464. Huggins DW (1979b) Cambendazole - nova substancia para o tratamento da estrongilo- idiase. Folha Med 34:373–375 [GEN 33:301–305 (1979)]Google Scholar
  465. Huggins DW (1979–1980a) Tratamento das enteroparasitoses com a associaçao tinida- zol+mebendazol+cambendazol. An Inst Hig Med Trop 6:1–4,45–48Google Scholar
  466. Huggins DW (1979—1980b) Essaio clinico com nova associaçao: tinidazol + flubendazol para o tratamento das enteroparasitoses. An Inst Hig Med Trop 6:41–43Google Scholar
  467. Huggings D, Ferreira RP, Xavier CC (1958) Dose unica do hydrato de piperazine na er- radicaçao da ascariase. Rev Soc Brasil Med Trop 2:255–257Google Scholar
  468. Hutchinson JGP, Johnston NM, Plevey MVP, Thangkhiew I, Aidney C (1975) A clinical trial of mebendazole. A broad-spectrum anti-helminthic. Br Med J 1:309—310Google Scholar
  469. Hutton PW, Somers K (1961) A comparison of bephenium hydroxynaphtoate with te- trachlorethylene in hookworm infestation. Trans R Soc Trop Med Hyg 55:431–434PubMedGoogle Scholar
  470. Huys J, Kayihigi J, Freyens P, Vandenberghe G (1973) Treatment of Ascaris infection with levamisole. Medikon 2:15–17Google Scholar
  471. Huys J, Vandenberghe G, Freyens P, Kayihige J (1976) Treatment of ankylostomiasis with levamisole. Afr J Med Sci 5:75–77Google Scholar
  472. Isebaert A (1970) Essai thérapeutique avec le R 17635 et son association avec le lévami- sole. Janssen Pharmaceutica, Clin Res Report, N 4 694Google Scholar
  473. Ishizaki T, Kitsumi H, Yasurakoa K, Hosaka Y (1963) The anthelmintic effects of hiabendazole against Ascaris, whipworm and hookworm infections in man. Jpn J Parasitai 12:182–185Google Scholar
  474. Islam N, Chowdury NA (1976) Mebendazole and pyrantel pamoate as broad spectrum anthelmintics. Southeast Asian. J Trop Med Public Health 7:81–84Google Scholar
  475. Ismail MM, Lionel NDW (1981) A comparative trial of flubendazole, flubendazole with levamisole, and mebendazole for mass anthelminthic treatment and an assessment of re-infection rates. JOICFP Research Project, Sri LankaGoogle Scholar
  476. Iswariah V, Naryana-Rao MS (1964) Thiabendazole: a new broad spectrum anthelminthic. J Assoc Physicians India 12:305–308PubMedGoogle Scholar
  477. Iwata S, Araki T, Ueda G, Kida A, Wada T, Kawata S (1963a) Notes on the treatment of human ascaris, trichuris, and enterobius infections with T. E. D. 3 as a broad spectrum anthelminthic. Jpn J Parasitol 12:174–181Google Scholar
  478. Iwata S, Araki T, Ueda G, Wada T, Kida A (1963b) Treatment of intestinal parasitosis with MK 360. Bull Osaka Med Sch 9:23–30PubMedGoogle Scholar
  479. Jancloes M, Jancloes-Diepart M (1981) Campagnes périodiques d’assainissement et de chimiothérapie de masse contre les nématodes intestinaux appliqués isolément et en combinaison au Bas Zaïre. Ann Soc Belg Med Trop 111–118Google Scholar
  480. Jancloes MF, Cornet P, Thienpont D (1979) Mass control of ascariasis with single oral doses of levamisole. Trop Geogr Med 31:111–112PubMedGoogle Scholar
  481. Janssen PAJ (1974) Recent advances in the treatment of parasitic infection in man. In: Juk- ker E (ed) Fortschritte der Arzneimittelforschung, vol 18. Birkhäuser, Basel, pp 191—203Google Scholar
  482. Janssens PG (1948) De AEX concentratie methode voor wormeieren. Ann Soc Belg Med Trop 28:213–220Google Scholar
  483. Janssens PG (1965) Les symptômes de la strongyloïdose. Ann Soc Belg Med Trop 45:131–150Google Scholar
  484. Janssens PG (1971) Anguillulose - aspects cliniques et thérapeutiques. Acta Gastroenterol Belg 34:301–321PubMedGoogle Scholar
  485. Janssens PG, Muynck A De, d’Arenberg St (1966) Thiabendazole, a sensational new anthelmintic agent (in Dutch). Ann Soc Belg Méd Trop 46:397–420Google Scholar
  486. Jaroonvesama N, Charoenlarp K, Muangmanee L, Saravich S, Aswapokee N, Saravich S (1978) Mebendazole, a new broad spectrum anthelminthic. J Med Assoc Thai 61:675—680PubMedGoogle Scholar
  487. Jayewardane LG, Ismail MM, Wijayaratnam Y (1960) Bephenium hydroxynaphtoate in the treatment of ascariasis. Br Med J 2:268–271Google Scholar
  488. Jeffery GM, Rondeau EA, Harrison AJ, Phifer KO (1963) Effects of stilbazium iodide on Enterobius vermicularis and other intestinal helminths. J Parasitol 49:639–641PubMedGoogle Scholar
  489. Johnson SC (1971) A comparative study of bitoscanate (jonit), bephenium hydroxynaphtoate and tetrachlorethylene in hookworm infection. J Trop Med Hyg 74:133–136PubMedGoogle Scholar
  490. Jorge J, Barbosa W (1964) Tratamento da estrongiloidose pelo tiabendazol. Rev Goiana Med 10:135–140Google Scholar
  491. Jung RC (1954) Use of hexylresorcinol tablet in enema treatment of whipworm infection. Am J Trop Med Hyg 3:918–921PubMedGoogle Scholar
  492. Jung RC, MacCroan JE (1960) Efficacy of bephenium and tetrachlorethylene in mass treatment of hookworm infection. Am J Trop Med Hyg 9:492–495PubMedGoogle Scholar
  493. Junod Ch (1965) Essai de traitement de la trichocephalose par la diphétarsone. Bull Soc Pathol Exot Filiales 58:653–660PubMedGoogle Scholar
  494. Juttijudata P, Guptavanij P, Harinasuta C (1962) A comparison of the efficacy of anthelminthic drugs in the treatment of hookworm infection. Jpn J Med Sei Biol 15:61—65Google Scholar
  495. Juwono R, Tantular K (1973) Clinical experience with mebendazole, a new broad spectrum anthelminthic. Janssen Pharmaceutica, Clin. Res. Report, N 5723Google Scholar
  496. Kaba AS, Luvwezo M, Nzuzi K, Thienpont D (1978) Le traitement anthelminthique périodique d’enfants d’âge scolaire au Zaire. Ann Soc Belg Med Trop 58:241–249PubMedGoogle Scholar
  497. Kadio A, Moreau J, Gazin J, Gaudet M (1982) L’Albendazole (Zentel®) dans le traitement de l’ankylostomiase en Côte d’Ivoire. Méd Afr Noire 29:27–28Google Scholar
  498. Kahn A A (1966) Practical aspects of the treatment of hookworm infection in Kampala children. Trans R Soc Trop Med Hyg 60:322–324Google Scholar
  499. Kale OO (1977) The anthelminthic efficacy of a mixture of pyrantel pamoate and oxantel pamoate. Curr Ther Res 22:802–806Google Scholar
  500. Kaminsky RG, Ndinya-Achola JO (1977) Oesophagostomum sp. from Kenya. Identification through tissue sections. East Afr Med J 54:296–297PubMedGoogle Scholar
  501. Kaminsky RG, Zimmerman RR (1977) Trichinella spiralis: incidental finding. East Afr Med J 54:643–646PubMedGoogle Scholar
  502. Kan SP (1979) Atypical nematode ova in a patient treated with pyrantel pamoate. Ann Trop Med Parasitol 73:397–398PubMedGoogle Scholar
  503. Kan SP (1982) Soil-transmitted helminthiasis in Selangor, Malaysia. Med J Malaysia 37:180–190PubMedGoogle Scholar
  504. Kan SP (1983a) The antihelminthic effects of flubendazole on Trichuris trichiura and Ascaris lumbricoides. Trans R Soc Trop Med Hyg 77:668–670PubMedGoogle Scholar
  505. Kan SP (1983b) The efficacy of single doses of flubendazole plus levamisole in the treatment of Trichuris and Ascaris infections. In: Yokogawa et al. (eds) Collected papers on the control of soil-transmitted helminthiases, vol 2. Asian Parasite Control Organisation, Tokyo, pp 145–149Google Scholar
  506. Kan SP (1983c) Efficacy of single doses of mebendazole in the treatment of Trichuris trichiura infection. Am J Trop Med Hyg 32:118–122PubMedGoogle Scholar
  507. Kan SP, Cheah JS (1970) Prevalence and intensity of helminthic infections in adults among the ethnic groups in Singapore. Singapore Med J 11:283–296PubMedGoogle Scholar
  508. Karnaukov VK, Ozeretskovskaya NN, Linewitch OM, Scherbakow AM, Djakomara AM, Drozdova TI, Laskovenko AI (1978) Clinical study of vermox (mebendazole) in trichocephalosis and other helminthiases. Janssen Pharmaceutica, Clin Res Report, N 14277Google Scholar
  509. Kato K, Miura M (1954) Comparative examinations. Jpn J Parasitol 3:35 (in Japanese)Google Scholar
  510. Katz M (1977) Anthelmintics. Drugs 13:124–136Google Scholar
  511. Katz N (1980) Dose-range study of flubendazole in the treatment of hookworm disease and trichiuriasis. Janssen Pharmaceutica, Clin Res Report, R 17 889/19Google Scholar
  512. Katz N, Zicker F, Chaves A, Antunes CMF (1972) Clinical trials with pyrantel pamoate in intestinal parasitoses. Rev Inst Med Trop Säo Paulo 14:212–221PubMedGoogle Scholar
  513. Kean BH, Hoskin DW (1964) Treatment of trichinosis with thiabendazole. A preliminary report. JAMA 190:852–853PubMedGoogle Scholar
  514. Keller AE, Leathers WS (1936) The incidence and distribution of Ascaris lumbricoides, Trichuris trichiura, Hymenolepis nana and Hymenolepis diminuta in 36 counties in Kentucky. Am J Hyg 23:216–230Google Scholar
  515. Kilala CP (1971) Ternidens deminutus infecting man in southern Tanzania. East Afr Med J 48:636–645PubMedGoogle Scholar
  516. Kilala CP, Chimbe A, Zikambona A (1970) Clinical trial of a new anti-hookworm drug: Jonit. In: Health and disease in Africa. East Afr Literature Bureau, NairobiGoogle Scholar
  517. Kilpatrick ME, Trabolsi B, Farid Z (1981) Levamisole compared to mebendazole in the treatment of Ancylostoma duodenale in Egypt. Trans R Soc Trop Med Hyg 75:578–579PubMedGoogle Scholar
  518. Klein E (1971) Single blind study in trichuriasis and ancylostomiasis. Janssen Pharmaceuti- ca, Clin Res Report, N 5 500Google Scholar
  519. Klein J, Zakharenko DF, Dolgina LE, Braginetz WR, Linko IA (1981) Etiotropic therapy and prophylaxis of trichinellosis. In: Kim ChW, Ruitenberg E J, Teppema JS (eds) Proc 5th intern conf trich. pp 291–296Google Scholar
  520. Kliks MM (1983) Anisakiasis in the Western United States: four new case reports from California. Am J Trop Med Hyg 32:526–532PubMedGoogle Scholar
  521. Kobayashi A (1970) Anthelminthic effect of pyrantel pamoate (Combantrin) against ascariasis (in Japanese). Jpn J Parasitol 19:296–300Google Scholar
  522. Kobayashi A (1971) Anthelmintic effect of pyrantel pamoate against hookworm infection. Jpn J Parasitol 20:52–57Google Scholar
  523. Kobayashi A (1980) Theory and practice applied in Japan for the eradication of Ascaris infection. In: Yokogawa M et al. (eds) Collected papers on the control of transmitted helminthiases. Asian Parasite Control Organization 1:232–242Google Scholar
  524. Koino S (1923) Infection experiments of ascariasis in human body. Jpn Med World 4:46–47Google Scholar
  525. Komiya Y, Kobayashi A, Ogawa H, Kumada M (1960a) Mass treatment of oxyuriasis with pyrvinium pamoate (Povan). Jpn J Parasitol 9:551–555Google Scholar
  526. Komiya Y, Kobayashi A, Kutsumi H, Kojima K, Kumada M, Ogawa H (1960b) On the mass treatment of hookworm infection. 4. The comparative study of the enthelmintic effect of 4-iodo-thymol and 1-bromonaphtol. Jpn J Parasitol 9:195–198Google Scholar
  527. Komiya Y, Mori Y, Yamauchi K (1962) Anthelminthic effect of pyrvinium pamoate (Po- quil) on pinworm with the administration in its smaller quantity. Jpn J Parasitol 11:390–392Google Scholar
  528. Kosin E (1973) Clinical trial with mebendazole (R 17 635) in schoolchildren. Janssen Phar- maceutica, Clin Res Report, N 6 683Google Scholar
  529. Kouri P, Valdez Dias R (1953) Concepto actual sobre el papel patogeno del Trichocefalo dispar (Trichuris trichiura). Sintomatologia gastro-intestinal particularmente ceco-ap- pendicular y recto-sigmoideana. Rev Kuba Med Trop Parasitol 8:37–41Google Scholar
  530. Krasa E, Kaupeny M (1977) Anthelmintika - Therapie mit Mebendazole bei Kindern mit bronchopulmonalen Erkrankungen. Paediatr Paedol 12:73–75Google Scholar
  531. Krotoski WA, Knudsen K, Cogswell FB, Conard R (1979) Efficacy of mebendazole against the helminth parasites of a Pacific Island population. 75th Annual meeting Tucson, November, Am Soc Trop Med HygGoogle Scholar
  532. Krubwa F, Gatti F, Lontie M, Vandepitte J, Thienpont D (1974a) Community-wide periodic anthelminthic treatment with levamisole. Ann Soc Belg Med Trop 54:167–176PubMedGoogle Scholar
  533. Krubwa F, Gatti F, Lontie M, Nguete K, Vandepitte J, Thienpont D (1974b) Administration trimestrielle de mebendazole en milieu scolaire suburbain. Med Trop 34:679–687Google Scholar
  534. Kuzmicki R, Gajda-Kazikowa E, Jozwiak S (1972) The results of treatment of helminthiasis with levatetramisole. Wiad Parazytol 18:73–77PubMedGoogle Scholar
  535. Kuzmicki R, Jozwiak SC, Gajda-Kazikowa E, Savrasewicz B (1979) Mebendazole treatment for human ascariasis. Janssen Pharmaceutica Clin Res Report N 17 518Google Scholar
  536. Kwo H, Jürsuf MA (1973) Efficacy of pyrantel pamoate (Combantrin) in the mass treatment of ascariasis and hookworm infections. Yonsei Rep Trop med 4:163–165Google Scholar
  537. Kwo EH, Kosman ML (1973) Treatment of intestinal parasites with mebendazole (R 17 635). Yonsei Rep Trop Med 4:166–167Google Scholar
  538. Labarriere F, Labarriere-Pollet E (1979) Contribution à l’étude de l’action antihelminthique du flubendazole à propos de 339 observations. Thèse, LilleGoogle Scholar
  539. Lacan A (1978) Considerations pratiques sur les présentations et les modalités d’utilisation des agents thérapeutiques en campagnes de masse. In: Marois M (ed) Development of chemotherapeutic agents for parasitic diseases. Elsevier, Amsterdam, pp 126–131Google Scholar
  540. Laengsvang S (1968) Further observations on the experimental transmission of Gnathos- toma spinigerum. Ann Trop Med Parasitol 62:88–94Google Scholar
  541. Lagunas Flores A (1979) Efectividad terapeutica del mebendazole en la trichocefalosis ma- siva. Salud Publica Mex 21:83–87PubMedGoogle Scholar
  542. Laigret J, Tourres M, Boschi S (1969) Action antihelminthique de l’isomère lévogyre du tetramisole. Bull Soc Pathol Exot Filiales 62:734–740PubMedGoogle Scholar
  543. Lambotte C, Bayoka S, Mulunda LE, Bosilo P (1960) L’Hydroxynaphtoate de bephenium dans l’ankylostomose du nourrisson et de l’enfant. Ann Soc Belg Méd Trop 40:771–781Google Scholar
  544. Lamina J (1980) Larva-migrans-visceralis-Infektionen durch Toxocara-Arten. Dtsch Med Wochenschr 105:796–797PubMedGoogle Scholar
  545. Lamson PD, Ward CB (1932) The chemotherapy of helminth infestations. J Parasitol 18:173–199Google Scholar
  546. Larivière M, Aziz MA, Diallo S, Diop Mar I, Porta M (1982) Efficacité et tolérance de l’ivermectine (MK 933) dans l’Onchocercose humaine. In: Coulaud JP, Gaxotte Ph (eds) Ophtalmologie tropicale. Onchocercose. La Française d’Edition et d’Imprimerie, Paris, pp 227–233Google Scholar
  547. Latonio AA (1973) Blind studies on three drugs in treatment of mixed nematodal infections. Philipp J Microbiol Infect Dis 2:59–69Google Scholar
  548. Latonio AA, Gonzales FA (1973) Open study of mebendazole in mixed nematodal infections. Philipp J Microbiol Infect Dis 2:47–58Google Scholar
  549. Layrisse M, Aparcedo L, Martinez-Torres C, Roche M (1967) Blood loss due to infection with Trichuris trichiura. Am J Trop Med Hyg 16:613–619PubMedGoogle Scholar
  550. Leao RN (1980) Dose-range study of flubendazole in the treatment of hookworm disease and trichiuriasis complicated or not by ascariasis. Janssen Pharmaceutica, Clin Res Report N 21274Google Scholar
  551. Lechat MF, Jancloes MF, Galambos FG, Cornet P, Thienpont D (1974) Control by leva- misole of ascariasis and ancylostomiasis in rural areas. Trop Geogr Med 26:441–445PubMedGoogle Scholar
  552. Lecomte-Ramioul S (1975) Traitement de l’oxyurase par le mébendazole. Schémas thérapeutiques applicables à une communauté d’enfants. Rev Méd Liège 30:733–736PubMedGoogle Scholar
  553. Lee En-L, Lyngkaran N, Gruve AW, Robinson MJ, Dissanaike AS (1975) Therapeutic evaluation of oxantel pamoate in severe Trichuris trichiura infection. Am J Trop Med Hyg 25:563–567Google Scholar
  554. Lee SH, Lim JK (1978) A comparative study of the effect of oxantel-pyrantel suspension and mebendazole in mixed infections with Ascaris and Trichuris. Drugs [Suppl 1] 15:94–98Google Scholar
  555. Lee SH, Seo BS, Cho SY, Kang SY (1976) Clinical trial of oxantel pamoate (CP-14445) on Trichocephalus trichiurus infection. Kor J Parasitol 14:25–31Google Scholar
  556. Leikina ES, Poletaeva OG (1980) Immunology of ascariasis. Intestinal Parasites S. G./WP/ 80,15. WHOGoogle Scholar
  557. Lenczner MM (1972) Treatment of trichiuriasis. Correspondence. Trans R Soc Trop Med Hyg 66:510–511Google Scholar
  558. Lengyel A, Rove J, Balle T, Lehoczky I (1973) New experiences in the therapy of ascariasis in children. Janssen Pharmaceutica, Clin Res Report, N 7280Google Scholar
  559. Lengyel A, Levai J, Rovo JT (1975) L’importance du mebendazole dans le traitement des infestations dues au Trichuris trichiura. Ther Hung 23:64–67Google Scholar
  560. Lengyel A, Albi I, Rovo TJ (1978) Mebendazole (Vermox) in the treatment of enterobiasis. Ther Hung 26:64–66Google Scholar
  561. Lepercq G (1974) Expertise clinique du mebendazole. Janssen Pharmaceutica, Clin Res Report, 8248Google Scholar
  562. Levai J, Lengyel A, Bank IG (1972) The first experiences with a new anthelminthic in Hungary. Janssen Pharmaceutica, Clin Res Report N 7 987Google Scholar
  563. Levi GC, Neto VA, Konichi SR, Stefani HNV (1972) Tratamento da ascaridiase em zona rural: estudo comparativo entre as actavidades de doses únicas de hexahidrato de pi- perazina, tetramisole e pamoate de pirantel. Rev Inst Med Trop Sao Paulo 14:392–396PubMedGoogle Scholar
  564. Levin ML (1983) Treatment of trichinosis with mebendazole. Am J Trop Med Hyg 32:980–983PubMedGoogle Scholar
  565. Lian WN, Zi ZY (1981) Observations on the prevalence and therapy of enterobius vermicu- laris infection among kindergarten children. Chin J Prevent Med 15:81 (abstract, WHO 82.5/10)Google Scholar
  566. Lie Kian Joe (1940) Helminthiasis of the intestinal wall caused by Oesophagostomum apios- tomum (Willach, 1891). Raillet and Henry 1905. Doc Neerl et Indones Trop 1:75–80Google Scholar
  567. Lim JK (1973) Anthelminthic effect of trans-1,4,5,6-tetrahydro-2-(3-hydroxystyryl)-l- methyl pyrimidine on Trichocephalus trichuris. Seoul J Med 14:228–232Google Scholar
  568. Lim JK (1974) Anthelminthic effect of oxantel pamoate against Trichocephalus trichiuris infection. Kor J Pharmacol 10:25–28Google Scholar
  569. Lim JK (1978 a) Anthelminthic effect of multiple intestinal helminthiasis with oxantel and pyrantel. Drugs [Suppl 1] 15:70–72Google Scholar
  570. Lim JK (1978 b) Anthelminthic effect of oxantel and oxantel-pyrantel in intestinal nematode infections. Drugs [Suppl 1] 15:99–103Google Scholar
  571. Limbos P, Muynck A De, Janssens PG (1968) Traitement de la trichocephalose par la di- phetarsone. Acta Gastroenterol. Belg 31:492–496Google Scholar
  572. Lionel NDW, Mirando EH, Nanayakkara JC, Soy sa PE (1969) Levamisole in the treatment of ascariasis in children. Br Med J 1:340–341Google Scholar
  573. Lionel NDW, Rafapakre L, Soy sa P, Aiyathurai JE J (1975) Mebendazole in the treatment of intestinal helminthiasis with special reference to whipworm infections. J Trop Med Hyg 78:75–77PubMedGoogle Scholar
  574. Lionel NDW, Silva DGH Da, Jayatilleka SMO (1980) Flubendazole in the treatment of intestinal helminthiasis. A comparative study using single dosage regimens. Janssen Pharmaceutica, Clin Res Report N 22140Google Scholar
  575. Lloyd EL (1959) Struggles with Sirongyloides. Practitioner 182:740PubMedGoogle Scholar
  576. Lopez Montero E, Calzada Sanchez JA (1975) Mebendazole en el tratiemento de las po- liparasitosis intestinales. Janssen Pharmaceutica, Clin Res Report, N 9 411Google Scholar
  577. Lorenz WA, Henglein A, Schräder G (1955) The new insecticide o,o-dimethyl 2,2,2- trichloro-l-hydroxy-ethyl-phosphonate. J Am Chem Soc 77:2554–2556Google Scholar
  578. Loria-Cortez R, Lobo-Sanahuja JF (1980) Clinical abdominal angiostrongylosis. A study of 116 children with intestinal eosinophilic granuloma caused by Angiostrongylus cos- taricensis. Am J Trop Med Hyg 29:538–544Google Scholar
  579. Loria-Cortez R, Lizano C, Chavarria AO, Villavicencio N, Calzada Castro LD (1974) Experience with mebendazole in children with multiple intestinal helminthiasis. Janssen Pharmaceutica, Clin Res Report, N 7 327Google Scholar
  580. Lormans JAG, Wesel AJT, Parijs OF Van (1975) Mebendazole (R 17635) in enterobiasis. Chemotherapy 21:255–260PubMedGoogle Scholar
  581. Loughlin EH, Mullin WG (1955) The treatment of enterobiasis with cristalline Oxytetracycline. Antibiot Med 1:145–150PubMedGoogle Scholar
  582. Loughlin EH, Rappaport I, Mullin WG, Wells HS, Shookhof HB (1951) The treatment of enterobiasis with Terramycin base. Antibiot Chemother 1:588–593Google Scholar
  583. Louw JH (1974) Biliary ascariasis in childhood. S Afr J Surg 12:219–225PubMedGoogle Scholar
  584. Louzada GZ, Louzada JLZ, Becker MdL, Louzada FZ, Agra HNC, Garcia PR, Garcia PC, Vasconcelos N (1973) Experimentacao clinica com mebendazole. Doenças infec- tiosas e parasitarias. Folha Med 66:317–334Google Scholar
  585. Lucas AO, Oduntan SO (1972) Treatment of hookworm infection and other intestinal parasites with L-tetramisole (Ketrax). Ann Trop Med Parasitol 66:391–398PubMedGoogle Scholar
  586. Luengo J, Barriga O (1966) Efecto del thiabendazole sobre différentes fases de la triquinosis experimental de la rata. Bol Chil Parasitol 27:2–11Google Scholar
  587. Lumbreras H, Guerra H, Ortiz-Valqui R, Tello R, Vega O (1974) Enterobiasis y ascariasis en un orfanatorio de Lima - tratamiento massivo con dosis única de pamoate de pyrantel. Acta Med Peru 3:185–190Google Scholar
  588. Lumbreras Cruz H, Tello R, Antunez A, Mayolo A De, Campos M, Guerra H, Soto J (1981) Ensayo terapeutico controlado de albendazol en helminthiasis intestinal. Compendium de Invest Clin Latino Americanas, I Simposio Latino americano Geohelmin- thiasis y albendazol. Cancun Mexico 1:104–109Google Scholar
  589. Lynch DM, Green E A, McFadzean JA, Pugh IM (1972) Trichuris trichiura infestations in the United Kingdom and treatment with difetarsone. Br Med J IV:73–76Google Scholar
  590. Lyndoh E, Barua P, Dutta S (1962) Bephenium hydroxynaphtoate in hookworm and other helminthic infestations. J Indian Med Assoc 39:350—353Google Scholar
  591. Maccowen M, Callender ME, Lawlis JF, Brandt MC (1953) The effect of erythromycin against certain parasitic organisms. Am J Trop Med Hyg 2:212–218Google Scholar
  592. Maccowen MC, Callender ME, Brandt MC (1957) The anthelminthic effect of dithiazanine in experimental animals. Am J Trop Med Hyg 6:894–897Google Scholar
  593. Mackay DM, Ahmed T, Ali S (1979) Pyrantel in the mass eradication of roundworm and hookworm. Health Hyg 2:123–125Google Scholar
  594. Mackerras MJ (1961) A promising new drug for the elimination of hookworms. Med J Aust 2:261–263Google Scholar
  595. Maisonneuve H, Piens MA, Mojon M, Garin JP (1981) L’albendazole. Evaluation de la tolérance et de l’efficacité dans l’oxyurose, la trichocephalose, l’ankylostomose, l’asca- ridiose, l’anguillulose. Bull Soc Pathol Exot Filiales 75:434–444Google Scholar
  596. Maka G (1963) Un oxyuricide des temps modernes: le pamoate de pyrvinium. Thése Méd, Lyon, no 118Google Scholar
  597. Maldonado JF (1965) Stilbazium iodide (monopar) in the treatment of human trichuriasis. Boi Asoc Med PR 57:57–66Google Scholar
  598. Mandour AM, Oman LAM (1976) Efficiency of levamisole Ketrax on some nematode infections in Assiat province. In: Proceedings of the 9th international congress of chemotherapy, July 1975, London, vol 6. Parasites, fungi, viruses. Plenum, New York, pp 97- 104Google Scholar
  599. Manson-Bahr Gh (1940) Phenothiazine as an anthelminthic. Lancet 2:808–809Google Scholar
  600. Mantovani A, Filippini I, Sachetti A, Bergomi S, Cavrini C, Marastoni G (1976) Observations sur un foyer de trichinöse humaine en Italie. Bull Acad Vet Fr 49:213–217Google Scholar
  601. Maqbool S, Lawrence D, Katz M (1975) Treatment of trichuriasis with a new drug, mebendazole. J Pediatr 86:463–465PubMedGoogle Scholar
  602. Margono S, Mahfudin H, Abidin AN, Rasad R, Rasidi R (1980) Flubendazole and ox- antel-pyrantel pamoate in the treatment of soil-transmitted helminths. Janssen Phar- maceutica Clin Res Report N 22139Google Scholar
  603. Markell EK (1968) Pseudohookworm infection - trichostrongyliasis. N Engl J Med 278:831–833PubMedGoogle Scholar
  604. Marroud J, Arfaa F, Jalali H, Key van S (1980) Prevalence of intestinal helminths in Khuzestan, S. W. Iran 1977. Am J Trop Med Hyg 29:389–392Google Scholar
  605. Martins NA, Gaburri DP (1974) Ensaio clinico com um novo anti-helmintico polivalente - o mebendazole. Folha Med 68:33–35Google Scholar
  606. Martirani I, Rodrigues LD (1976) Ensaio clinico com o cambendazole, urna nova droga na terapeutica anti-helmintica (nota previa). Rev Inst Med Trop Sao Paulo 18:71–75PubMedGoogle Scholar
  607. Martirani I, Soares W, Rodrigues LD, Ferreira LE, Ayres N, Aguiar Filho E (1976) Cambendazole - um nova antelmintico. Estuerdos de biovaliabilidade. Folha Med 73:11—14Google Scholar
  608. Marx R, Tonthanien (1961) Essais de traitement de l’ankylostomose en Viet-Nam par l’hydroxynaphtoate de bephenium. Bull Soc Pathol Exot Filiales 54:844–850Google Scholar
  609. Mathies AW (1961) Enterobius vermicularis infection. Certain aspects of host-parasite relationship. Am J Dis Child 101:174–177PubMedGoogle Scholar
  610. Mathies AW (1969) Thiabendazole in the treatment oC Enterobius vermicularis. Tex Rep Biol Med [Suppl 2] 27:611–614Google Scholar
  611. Mathies AW (1973) The efficacy of mebendazole in the treatment of Enterobius. Janssen Pharmaceutica, Clin Res Rep N 7 331Google Scholar
  612. Meenakshi Shah (1979) Clinical evaluation of mebendazole in trichuriasis in children. Indian Pediatr 16:267–270PubMedGoogle Scholar
  613. Mehrez R (1947) Les nouveaux traitements de l’oxyurose. Thése Méd no 546, ParisGoogle Scholar
  614. Mehrotra MP, Malaviya VS (1963) Single dose treatment of hookworm disease with be- phenium hydroxynaphtoate. Indian J Med Sci 17:930–933PubMedGoogle Scholar
  615. Meira DA, Neto VA, Campos R (1961) Tratamento da estrongiloidiase pelo pamoate de pirvinio. O Hospital 59:1135–1138PubMedGoogle Scholar
  616. Mejia R, Biagi F (1959) El ioduro de dithiazanina en algunas helminthiasis. Med Mex 39:346–348Google Scholar
  617. Merdivenci A, Samasti M, Baturalp I (1977) Trihuriyazin mebendazole ile iyiletimi uzerine arastirnalar. Turk Microbiol Cem Derg 7:45–53Google Scholar
  618. Migasena S, Suntharasamai P, Harinasuta T (1978) Mebendazole, tetrachlorethylene and pyrantel pamoate in the treatment of hookworm infection. Ann Trop Med Parasitol 72:199–200PubMedGoogle Scholar
  619. Miller JH, Anthony SO, Swarzwelder JC, Frye WW, Lampert R (1958) Treatment of enterobiasis with dithiazanine. Am J Digest Dis 3:229–231PubMedGoogle Scholar
  620. Miller M J (1976) Protozoan and helminth parasites - A review of current treatment. In: Jucker E (ed) Progress in drug research. Birkhaeuser, Basel, pp 433–464Google Scholar
  621. Miller MJ (1980) Use of levamisole in parasitic infections. Drugs 19:122—130Google Scholar
  622. Miller MJ, Arfaa F (1975) Levamisole compared with piperazine citrate in the treatment of schoolchildren with ascariasis. Janssen Pharmaceutica Clin Res Report N 10443Google Scholar
  623. Miller MJ, Katz N (1975) Single oral doses of levamisole and of piperazine citrate in the treatment of children with ascariasis. Janssen Pharmaceutica, Clin Res Report, N 10 444Google Scholar
  624. Miller MJ, Krupp IM, Little MD, Santos C (1974) Mebendazole, an effective anthelmin- thic for trichuriasis and enterobiasis. JAMA 230:1412–1414Google Scholar
  625. Miller M J, Krupp IM, Little MD (1976) Placebo-controlled comparison of levamisole with pyrantel pamoate in the treatment of ascariasis in children. Janssen Pharmaceutica, Clin Res Report, N 10543Google Scholar
  626. Miller MJ, Farahmandian I, Arfaa F, Katz N, Winsor E, Bennett E (1978) An evaluation of levamisole for treatment of ascariasis. South Med J 71:137–140PubMedGoogle Scholar
  627. Misra SS, Misra RN, Soleja MZ (1965) A trial of bephenium hydroxynaphtoate in ankylostomiasis. J Assoc Physicians India 13:199–204PubMedGoogle Scholar
  628. Misra A, Visen PKS, Katiyar JC (1981) Comparative efficacy of standard antihookworm drugs against various test nematodes. J Helminth 55:273–278PubMedGoogle Scholar
  629. Mittermayer T, Spaldonova R (1981) The use of mebendazole in the treatment of trichinel- losis in man. Folia Parasitol 28:235–242PubMedGoogle Scholar
  630. Mittermayer T, Chroust K, Dedina L, Simunova M (1978) Clinical and therapeutical experience of trichinosis treated with thiabendazole and mebendazole. Cas Lek Ces 117:1053–1056Google Scholar
  631. Mittermayer T, Cisarova A, Carnicka A, Magyar B, Maloveska M, Schreter I (1979) Acute trichinellosis with neurological and mental manifestations treated with mebendazole andcorticoids. CasLék Ces 118:1175–1179Google Scholar
  632. Miyazaki I (1960) On the genus Gnathostoma and human gnathostomiasis, with special reference to Japan. Exp Parasitol 9:337–370Google Scholar
  633. Miyazaki I (1966) Gnathostoma and gnathostomiasis in Japan. In: Progress of medical parasitology in Japan. Meguro Parasitological Museum, TokyoGoogle Scholar
  634. Miyazaki L (1968) On the genus Gnathostoma and human gnathostomiasis, with special reference to Japan. Exp Parasitol 62:88–94Google Scholar
  635. Moens M, Dom J, Burke WE, Schlossberg S, Schuermans V (1978) Levamisole in ascariasis - A multicenter controlled evaluation. Am J Trop Med Hyg 27:897–904PubMedGoogle Scholar
  636. Mojon M, Piens MA (1982) L’Albendazole et anguillulose. Méd Afr Noire 29:9–14Google Scholar
  637. Mojon M, Melet V, Durand-Peyre F, Jacquet M (1981) Anguillulose et albendazole. Lyon Med 245:99–104Google Scholar
  638. Mojon M, Cadi-Soussi M, Excler JL (1982) Efficacité de l’albendazole en prise unique dans le traitement de l’ankylostomiase. Essai thérapeutique mené en double aveugle. Méd Afr Noire 29:5–8Google Scholar
  639. Molina Pasquel Cl, Diaz Munoz A (1959) Effectividad del tetradoretileno emulsionado en el tratamiento de la uncinariasis. Rev Inst Salubr Enferm Trop (Mexico) 19:11–14Google Scholar
  640. Montero LE, Sanchez CJA (1975) Mebendazole en el tratamento de las poliparasitosis intestinales. Janssen Pharmaceutica Clin Res Rep N 9 411Google Scholar
  641. Moreau JP, Lagraulet J (1972) Survie „in vitro des larves de troisième stade d’Angiostron- gylus cantonensis. Ann Parasitol Hum Comp 47:525–529PubMedGoogle Scholar
  642. Morera P (1979) Life histroy and redescription of Angiostrongylus costaricensis Morera and Cespedes. Am J Trop Med Hyg 22:613–622Google Scholar
  643. Morera P, Cespedes R (1971) Angiostrongilosis abdominal. Una nueva parasitosis huma- na. Acta Med Cost 14:159–173Google Scholar
  644. Morera P, Perez FR, Mora F, Castro L (1982) Visceral larva migrans-like syndrome caused by Angiostrongylus costaricensis. Am J Trop Med Hyg 31:67–70PubMedGoogle Scholar
  645. Moser RH (1974) From Bismark to Polar bears. JAMA 228:735–737 Most H (1963) Treatment of the more common worm infections. JAMA 185:874–877Google Scholar
  646. Most H, Yoeli M, Champbell WC, Cuckler C (1965) The treatment of Strongyloides and En- terobius infections with thiabendazole. Am J Trop Med Hyg 14:379–382PubMedGoogle Scholar
  647. Mouriquand G, Roman E, Coisnard J (1951) Essai de traitement de l’oxyurose par la pi- pérazine. J Med Lyon 32:189–195PubMedGoogle Scholar
  648. Mouriquand G, Roman E, Coisnard G (1953) Traitement de l’oxyurose infantile par le pi- pérazine. Rev Kuba Med Trop Parasitol 9:37–38PubMedGoogle Scholar
  649. Müller G (1953) Untersuchungen über die Lebensdauer von Ascarideneiern in Gartenerde. ZBakteriol Parasitol Infektionskrankheiten Hyg Orig 159:377–379Google Scholar
  650. Müller RW (1949) Über die Allergie und Immunität bei der Ascaris Infektion des Menschen. Z Hyg Inf Krank 130:28–35Google Scholar
  651. Mullin WG, Imperato P (1969) Treatment of oxyuriasis with thiabendazole. Tex Rep Biol Med [Suppl 2] 27:615–621Google Scholar
  652. Musgrave I A, Hawes RB, Jameson JL, Sloane RA, Quayle PA (1979) Mebendazole: evaluation of a new antihelminthic for trichiuriasis, hookworm and strongyloidiasis. Med JAust 1:403–405Google Scholar
  653. Mutalik GS, Gulati RB (1969) Clinical trial of bitoscanate (jonit) in hookworm disease. Clin Pharmacol Ther 10:635–637PubMedGoogle Scholar
  654. Mutalik GS, Gulati RB (1972) Comparative clinical trial of bitoscanate, bephenium hy- droxynaphtoate and tetrachlorethylene in hookworm infection. Indian J Med Sci 26:718–722PubMedGoogle Scholar
  655. Mutalik GS, Balwani JH, Pal VR, Joglekar GV (1964) 4-Iodothymol (thymolan) in the treatment of ankylostomiasis. J Trop Med Hyg 67:75–76Google Scholar
  656. Mutalik GS, Gulati RB, Iqbal AK (1970) Evaluation of phenylene 1,4-di-isothiocyanate (bitoscanate: Jonit®) in intestinal parasitic infection: a field study. Ann Trop Med Parasitol 64:79–85PubMedGoogle Scholar
  657. Muttalib UA, Kahn MV, Hacq JA (1981) Single dose regime of mebendazole in the treatment of polyparasitism in children. J Trop Med Hyg 84:159–160PubMedGoogle Scholar
  658. Nagalingam I, Lam LE, Robinson MJ, Dissanaike AS (1976) Mebendazole in treatment of severe Trichuris trichiura infection in Malaysian children. Am J Trop Med Hyg 25:568–572PubMedGoogle Scholar
  659. Nagaty HF, Rifaat MA (1959) Clinical trials with bephenium hydroxynaphtoate against Ancylostoma duodenale and other helminthic infestations. J Trop Med Hyg 62:255–258PubMedGoogle Scholar
  660. Nagaty HF, Mohajeri M, Elahi R (1978) Clinical trial of levamisole in the treatment of ascariasis in Khorasan, Iran. J Trop Med Hyg 81:195–197PubMedGoogle Scholar
  661. Nakasato H (1974) Immunoglobulin levels in helminthic infections: ancylostomiasis, ascariasis, and trichiuriasis. Jpn J Parasitol 23:325–334Google Scholar
  662. Narmada R, Jagadesewara RM, Adinaraynan P, Balagopal Raju V (1974) Study on oxyuriasis and trichuriasis in children and evaluation of mebendazole. Indian Pediatr 11:417–419PubMedGoogle Scholar
  663. Narmada R, Jagadeeswara RM, Balagopal RV (1977) Study of oxyuriasis in families. Jans- sen Pharmaceutica, Clin Res Report, N 13712Google Scholar
  664. Nassif S, Bell WJ, Prescott JEG (1974) Comparison of pyrantel pamoate syrup and pyr- vinium pamoate syrup in the treatment of enterobiasis in Egypt. J Trop Med Hyg 77:270–271PubMedGoogle Scholar
  665. Nauenberg W, Edelman MH, Spingarn CI (1970) Observations on the treatment of strongyloidiasis with thiabendazole in New York City. Mt Sinai J Med 37:607–611PubMedGoogle Scholar
  666. Navarro-Hildago A, Uribe J de R (1962) Ensayos sobre tratamientos colectivos de la helminthiasis intestinal en la edad escobar. Rev Invest Bol Univ (Guadalajara) 2:253–260Google Scholar
  667. Nelson GS, Richman R, Pester FRN (1961) Feral trichinosis in Africa. Trans R Soc Trop Med Hyg 55:514–517PubMedGoogle Scholar
  668. Neyrinck B, Kerckhove N Van de (1976) Flubendazole. Single oral doses in adult patients which ascariasis, trichiuriasis and for hookworm. Janssen Pharmaceutica Clin Res Report N 11655Google Scholar
  669. Ngoy K, Kalombo M (1975) Therapeutical effectiveness and safety of 2% mebendazole syrup in various helminthiasis. Janssen Pharmaceutica, Clin Res Report N 9 537Google Scholar
  670. Ninane G, Poffe F (1959) Essai clinique de l’hydroxynaphtoate de bephenium dans l’anky- lostomiase. Ann Soc Belg Méd Trop 39:887–892Google Scholar
  671. Ninane G, Brakel J, Coster P De (1957) A propos de l’emploi de l’adipate de piperazine pour le traitement de masse de l’ascaridiose. Ann Soc Belg Méd Trop 37:279–284Google Scholar
  672. Nishimura T, Okumara T, Sakaguchi H, Maeyama T, Takahashi N (1965) Pinworm infection in children and its mass treatment with a small dose of pyrvinium pamoate. Jpn J Parasitol 14:204–212Google Scholar
  673. Nitzulescu V (1971) Traitement de l’ascaridiose par le chlorhydrate de L-tretramisole (De- caris). Janssen Pharmaceutica, Clin Res Report N 5 617Google Scholar
  674. Nitzulescu V, Simionescu O, Lucian O, Corijescu V, Brinzei A, Juvara AM (1970) Le traitement de la trichocéphalose par le Bemarsal. Bull Soc Pathol Exot Filiales 63:251–255PubMedGoogle Scholar
  675. Nozais JP (1978) Etude de l’activité du fluoromebendazole (flubendazole) sur Ascaris lum- bricöides, Necator americanus et Trichuris trichiura en pays d’endémie. Méd Afr Noire 25:473–475Google Scholar
  676. O’Holohan DR, Hugoe-Matthews J (1972) Single dose regimens of phenylene-di-isothio- cyanata (1,4), Jonit, in the treatment of hookworm infestation in Malaysia. Southeast Asian. J Trop Med Public Health 3:403–410Google Scholar
  677. Oishi K, Nagano K, Suzuki M (1974) Pathogenic capacity of anisakinae larvae from cod/ and Alaska pollack. Proc 3rd int congr Parasitol, München G2 (22), Facta Publication, H Egermann, Al 170 Vienna, p 1626Google Scholar
  678. Ora M, Klein I, Cohen S, Meital Z (1976) Comparative efficacy of levamisole and piperazine in ascariasis. Janssens Pharmaceutic Clin Res Report N 10 594Google Scholar
  679. Orban A (1972) Mass treatment of a Congolese population with a single oral dose of evamisole. Janssen Pharmaceutica, Clin Res Report N 5 898Google Scholar
  680. Oshima T (1972) Anisakis and anisakiasis in Japan and adjacent area (1). In: Morishita K,Google Scholar
  681. Koffiiya Y, Matsubayashi H (eds) Progr Med Parasitol in Japan, vol 4, pp 303–393Google Scholar
  682. Otero DR, Galvez OM, Estevez CB (1977) Primer ensayo clinico-terapeutico en Cuba con mebendazol en algunas helminthiasis. Rev Cubana Med Trop 29:13—16Google Scholar
  683. Owings RS (1955) Pinworms and Oxytetracycline. Some of the symptoms before treatment. Antibiot Med 1:280–282PubMedGoogle Scholar
  684. Ozeretskovskaya NN (1968) The clinical and epidemiological peculiarities of trichinellosis originating from the different geographical regions of the USSR. Med Parazitol 34:387–397Google Scholar
  685. Ozeretskovskaya NN, Pereverzeva EV, Tumolskaya NI, Bronshtein AM, Morenez TM, Imamkuliev KD (1976) Benzimidazoles in the treatment and prophylaxis of synanthro- pic and sylvatic trichinellosis. In: Kim Chw, Pawlowsky ZS (eds) Proc 4th int conf trich University Press of New England, Hannover, New Hampshire, pp 381–393Google Scholar
  686. Ozeretskovskaya NN, Morenetz TM, Pereverzeva EV, Bronstein AM, Veretennikova NL, Kolosova MO, Poverenny AM, Podgorodnichenko VK, Kagorodin DA (1981) Therapeutical properties of benzimidazoles in trichinellosis and the side effects of the treatment. In: Kim ChW, Ruitenberg EJ, Teppema JS (eds) Trichinellosis. Proceedings of the 5th international conference on trichinellosis. Reedbooks, Chertsey SurreyGoogle Scholar
  687. Padelt H, Hölzer E, Steinrück M (1977) Neue Aspekte in der Therapie des Wurmbefalls. Janssen Pharmaceutica, Clin Res Report N 13 276Google Scholar
  688. Paine DHD, Lower ES, Cooper TV (1960) Treatment of trichuriasis with dithiazanine in a hospital for mental defectives. Br Med J 1:770–774PubMedGoogle Scholar
  689. Palacios y Saucedo (1973a) Estudio pediatrico (40 casos) de un antihelmintico de amplio spectro. Janssen Pharmaceutica, Clin Res Report N 7 575Google Scholar
  690. Palacios y Saucedo J (1973 b) Estudio pediatrico (40 casos) de un antihelmintico de amplio spectro. Status Report, MexicoGoogle Scholar
  691. Palmer ED (1950) A note on the treatment of strongyloidiasis with intravenous gentian violet. Am J Trop Med 30:91–92Google Scholar
  692. Pampinglione S, Ricciardi ML (1971) The presence of Strongyloides fulleborni von Linstow 1905, in man in central and east Africa. Parasitologia 13:257–269Google Scholar
  693. Pampiglione S, Baldelli R, Corsini C, Mari S, Mantovani A (1978) Infezione Sperimentale del Cavallo con Larve di Trichina. Parasitologia 20:183–193Google Scholar
  694. Pandey KN, Saratchandra S, Sarin G, Ajmani NK, Chuttani HK (1971) Pyrantel pamoate in treatment of hookworm infestation. Br Med J 4:399–400PubMedGoogle Scholar
  695. Papasarathorn T, Chularenk U, Tongkoom B (1964) Studies on therapeutic effects of thiabendazole (MK 360) against ascariasis, trichuriasis, strongyloidiasis and hookworm infections in man. Jpn J Med Sci Biol 17:217—221PubMedGoogle Scholar
  696. Paramaeswaran H, Lung TK (1979) Mebendazole in the treatment of symptomatic trichuriasis. A preliminary efficiency report. Janssen Pharmaceutica, Clin Res Report N 7,223Google Scholar
  697. Park C-W, Lim J-K, Shim S-J, Kim M-S, Chung M-H (1973) Anthelmintic effect of trans- 1,4, 5,6, tetrahydro-2-(3-hydroxystyryl)-l methyl pyrimidine (CP 14445) on Trichoce- phalus trichiuris. Seoul J Med 14:228–232Google Scholar
  698. Partono F, Purnomo, Tangkilisan A (1974) The use of mebendazole in the treatment of polyparasitism. Southeast Asian J Trop Med Public Health 5:258–264PubMedGoogle Scholar
  699. Pascual J, Bouli RP, Aguiar H (1981) Eosinophilic meningoencephalitis in Cuba, caused by Angiostrongylus cantonensis. Am J Trop Med Hyg 30:960–962PubMedGoogle Scholar
  700. Patel KM, Olweny CLM (1972) Comparison of bitoscanate (Jonit) and tetrochlorethylene in treatment of N. americanus infection. East Afr Med J 49:270–272Google Scholar
  701. Patron F, Zavala J, Carranza J (1973) Evaluacion del efecto antitrichocefalosica del ebendazole. Rev Coleg Medicos Yucatan 2:12–19Google Scholar
  702. Paugrain J, Delavat A (1970) Bilan de l’action anthelminthique de l’isomère levogyre du tetramisole en Polynésie Française. Bull Soc Pathol Exot Filiales 63:507–513Google Scholar
  703. Paul FM, Zaman V (1975) A trial of mebendazole in trichuriasis (whipworm) infestation in Singapore children. Singapore Med J 16:11–18Google Scholar
  704. Paul FrM, Zaman V (1976) A trial of oxantel in trichiuriasis. Singapore Med J 17:219–224Google Scholar
  705. Paviot J J, Nioguy C (I960) Essais d’un nouvel anthelminthique sel de bephenium. Bull Soc Pathol Exot Filiales 53:806–809Google Scholar
  706. Pawlowski ZS (1981) Control of trichinellosis. In: Kim ChW, Ruitenberg EJ, Teppema JS (eds) Proc 5th int congr trich. Reedbooks, Chertsey, Surrey, England, pp 7–20Google Scholar
  707. Pawlowski Z, Chodera L (1975) Mebendazol - Nowy Lek Przeciw Robaczycom. Pol Tyg Lek 30:1035–1037PubMedGoogle Scholar
  708. Pena-Chavarria A (1977) Efficacy of one to two grams of flubendazole in the treatment of trichuriasis. Janssen Pharmaceutica, Clin Res Report N 12 865Google Scholar
  709. Pena-Chavarria A, Villarejos VM (1975) Cure, egg reduction and reinfestation rates in children with ascariasis after single oral doses of anthelminthics: a placebo-controlled comparison of levamisole with pyrantel pamoate. Janssen Pharmaceutica, Clin Res Report N 10384Google Scholar
  710. Pena-Chavarria A, Lizano C, Courtney KO, Thompson PE (1963) The effect of trichlor- fenol piperazine in patients parasitized by hookworms, ascarids, or trichurids. Am J Trop Med Hyg 12:378–382PubMedGoogle Scholar
  711. Pena-Chavarria A, Swartzwelder JC, Villarejos VM, Kotcher E, Arguedas J (1969) Dichlorvos, an effective broad spectrum anthelminthic. Am J Trop Med Hyg 18:907- 911Google Scholar
  712. Pena-Chavarria A, Swartzwelder JC, Villarejos VM, Zeledon R (1973) Mebendazole, an affective broad-spectrum anthelminthic. Am J Trop Med Hyg 22:592–595Google Scholar
  713. Pene P, Ngembi N’Bina C, Vincentelli JM, Bourderioux CH, Rossignol JF (1981 a) El Al- bendazol en ninos. In: 1st simp latino-americano geohelminthiasis y albendazol. Comp de Invest Clin Latino-americanas, Cancun, pp 114–116Google Scholar
  714. Pene P, Vicentelli JM, Soula G, Bourderioux CH, Rossignol JF (1981 b) Le zentel (albendazole) dans le traitement des nématodoses intestinales. Etude multicentrique en Afrique de l’Ouest. A propos de 390 observations. Med Afr Noire 28:483–485Google Scholar
  715. Pene P, Mojon M, Garin JP, Coulaud JP, Rossignol JF (1982a) Albendazole: a new broad spectrum anthelminthic. Double blind multicenter clinical trial. Am J Trop Med Hyg 31:263–266PubMedGoogle Scholar
  716. Pene P, Coulaud JP, Soula G, Rossignol JF, Monges P, Chaudet H (1982b) Le zentel® dans le traitement des helminthiases intestinales en Afrique de l’Ouest. Med Afr Noire 29:43–48Google Scholar
  717. Penot C, Picot H, Lavarde V (1978) Essai thérapeutique d’un nouvel anti-helminthique en Amazonie columbienne: le flubendazole. Bull Soc Pathol Exot Filiales 71:370–375PubMedGoogle Scholar
  718. Pereira JFV, Ghosh HK, Conklin S, Ryan S (1979) Mebendazole therapy of whipworm infestation. Med J Aust 1:134–135PubMedGoogle Scholar
  719. Phillips AP, Burrows RB (1961) Pyridine derivatives with anthelminthic activity. Nature 191:707–708PubMedGoogle Scholar
  720. Phills J A, Harrold A J, Whitman GV, Perelmutter L (1972) Pulmonary infiltrates, asthma and eosinophilia due to Ascaris suum infestation in man. N Engl J Med 286:965–975PubMedGoogle Scholar
  721. Piekarski G (1975) Medizinische Parasitologic in Tafeln. Springer, Berlin Heidelberg New YorkGoogle Scholar
  722. Pigott J, Hansburger EA Jr, Heafie RC (1970) Human ascariasis. Am J Clin Pathol 53:223- 234Google Scholar
  723. Pitts NE, Migliardi JR (1974) Antiminth (pyrantel pamoate). The clinical evaluation of a new broad-spectrum anthelminthic. Clin Pediatr 13:87–94Google Scholar
  724. Pizzi TE, Schenone H (1951) Haltazgo de huevos de Trichuris trichiura en contenido intestinal de un cuerpo arqueologico incaico. Bol Chil Parasitol 9:73–75Google Scholar
  725. Plotnikow NN, Ozeretskovskaya NN, Ananina NO (1962) Therapeutic efficacy of dithiazanine and degree of its tolerance in trichuriasis. Med Parazitol 31:515–521 (in Russian)Google Scholar
  726. Pobee JOM, Amissah JK (1970) Clinical trial of a new anti-hookworm drug phenylene di- isothiocyanate (1,4) Jonit®. Ghana Med J 9:98–101Google Scholar
  727. Polak MF, Kapmelmacher EH (1967) Haringwormziekte in 1965 en in de voorgaande jaren. Versl Meded Volksgezondh 12:344Google Scholar
  728. Pond HS, Bokat RB, Johnson JP, Knight JL, Healy GR, Gleason NN, Hall ER (1970) Mass treatment for ascariasis: value of prophylactic use of piperazine in groups heavily infected with Ascaris lumbricoides. South Med J 62:599–602Google Scholar
  729. Pradatsundarasar A, Pecharanon K, Chintanawongs C, Ungthavorn P (1973) The first case of intestinal capillariasis in Thailand. Southeast Asian J Trop Med Public Health 4:131–134PubMedGoogle Scholar
  730. Prakash O, Banerjee D, Sama SK (1970) A clinical trial of tetramisole (R 8299) in cases of ascariasis. Indian J Med Res 58:1578–1583PubMedGoogle Scholar
  731. Purnomo, Partono F, Soewarta A (1980) Human intestinal parasites in Karakuak, West Flores, Indonesia, and the effect of treatment with mebendazole and pyrantel pamoate. Southeast Asian J Trop Med Public Health 11:324–331PubMedGoogle Scholar
  732. Rachelson MH, Ferguson WR (1955) Piperazine in the treatment of enterobiasis. Am J Dis Child 89:346–349Google Scholar
  733. Radoev V (1974) The efficacy and tolerance of l-tetramisol (Decaris) in the treatment of nematode infections. Probl Zaraz Paraz Boleste 2:261–271Google Scholar
  734. Ramalingham Sh, Sinniah B, Krishnan U (1983) Albendazole, an effective single dose, broad spectrum anthelmintic drug. Am J Trop Med Hyg 32:984–989Google Scholar
  735. Ramirez Martinez J, Maya Ugalde R (1973) Tricocefalosis: valoración clinica de un neuevo antihelmintico. El Medico de Mexico 9:59–62Google Scholar
  736. Ranque PH, Soula G, Espieu C, Kessalis N (1982) Traitement de l’ankylostomose au Mali par l’albendazole (Zentel®). A propos de 137 observations. Méd Afr Noire 29:19–22Google Scholar
  737. Ricci M, Corbo S (1956) Sull’azione dell’idrato di piperazina verso Enterobius vermicularis. Recon Inst Sup Sanita 19:230–239Google Scholar
  738. Ricci M, Corbo S (1957) Sull’azione dell’adipato di piperazina verso e. vermicularis e a. lumbricoides. Reon 1st Super Sanita 20:258–260Google Scholar
  739. Ricci M, Frederico A (1972) Experimento di lotta contro l’ascaridiasi nel comune di parenti (Cosenza). Riv Parasitol 38:209–218Google Scholar
  740. Richard-Lenoble D, Gentilini M (1980) Nematodoses intestinales au Gabon et et mebendazole (vermox). Janssen Pharmaeeutica, Clin Res Report N 18 928Google Scholar
  741. Richard-Lenoble D, Kombila M, Maganga ML, Gentilini M (1981) Mebendazole et nematodoses intestinales au Gabon. Bull Soc Pathol Exot Filiales 74:444–450PubMedGoogle Scholar
  742. Richard-Lenoble D, Kombila M, Gassita F, Coniquet C (1982) L’Albendazole (Zentel®): traitement des nematodoses intestinales au Gabon. Med Afr Noire 29:37–39Google Scholar
  743. Rim HJ, Lim JK (1972) Treatment of enterobiasis and ascariasis with Combantrin (pyrantel pamoate). Trans R Soc Trop Med Hyg 66:170–175PubMedGoogle Scholar
  744. Rim HJ, Lim JK, Seo BS (1975) Anthelminthic effect of Combantrin (pyrantel pamoate) against intestinal nematodes in Korea. Proc 10th SEAMEO TROPMED Seminar. Korean J Parasitol 13:97–101Google Scholar
  745. Rim H-J, Chang Yu-Sh, Ha JHw, Lim J-K (1976) Anthelmintic effect of oxantel pamoate (CP 14445) against trichuriasis. Kor Un Med J 13:205–211Google Scholar
  746. Rim H-J, Joo K-H, Kim Y-Y, Lee JS, Song S-D (1980) Anthelminthic effect of Amidantel (Bay d 8 815) against Ancylostoma duodenale infection. Korean J Parasitol 18:24–36Google Scholar
  747. Rim H-J, Lee J-S, Joo Ky-Hw, Kim Yu-Sh (1981) Anthelminthic effects of fenbendazole and oxantel-pyrantel pamoate to the intestinal-nematodes. Korean J Parasitol 13:97–101Google Scholar
  748. Rizzotti G (1952) Risultati della cura con violetto de genziana per via orale nella infesta- zione de Strongyloides stercoralis. Riv Parasitol 13:315–320Google Scholar
  749. Rodrigues LD, Vilela M de P, Capell JI (1966) Novo anti-helminthics [ciclamato de 2,3,5,6- tetrahidro-6-penilimidazo-(2,l-B/Tiazol)j na ascariase humana. Rev Bras Med 23:861— 866Google Scholar
  750. Rodrigues LD, Vilela M de P, Capell JI (1967 a) O tratamento da ascariase e de outras pa- rasiteses intestinais humanes pelo ciclamato de tetramisol. O Hospital 71:1757–1770Google Scholar
  751. Rodrigues LD, Vilela M de P, Capell JI, Mello E De BF, Reibscheid S (1967 b) Tratamento da ascaridiase com dosa unica de fumarato de piperazina. Rev Brasil Med 24:442–446Google Scholar
  752. Rodrigues LD, Martirani I, Cabeca M, Soares W, Brandao J A (1977) Cambendazol novo anti-helmintico na terapeutica da estrongiloidiase humana. Experimentacao clinica. Rev Inst Med Trop Sao Paulo 19:57–67PubMedGoogle Scholar
  753. Rodrigues YT, Pecego GF, Coura LC, Negrisoli D, Galvao-Pereira FA, Rodriguez da Sil- va J (1960) Tratamento da oxiurase com dosa unica de pamoate de pirvinio. J Pediatr 25:324–330Google Scholar
  754. Rodrigues de Curet H, Valiaga MP, del Pilar (1968) Dithiazanine intoxication, a case report. Bol Ass Med P Rico 55:469–472Google Scholar
  755. Rodrigues Pavon A (1973) Estudio de la accion del mebendazole en la trichocefalosis. Status Report, MexicoGoogle Scholar
  756. Rodriguez da Silva J, Camillo-Coura L, Tinoco de Carvalho H, Almeida-Lopes PF (1968) Tratamento da estrongylioidase. Resultados preliminares da ensaio com un novo enti- helmintico o thiabendazol. O Hospital 63:247–264Google Scholar
  757. Roels-Broadhurst D, Mayer EM De (1957) Le phosphate de piperazine comme moyen deGoogle Scholar
  758. traitement de l’ascaridiose en milieu coutumier. Ann Soc Beige Med Trop 37:925–931Google Scholar
  759. Rombaut N, Scheijgrond H, Parijs O Van (1975) Flubendazole in enterobiasis. A placebo- controlled study. Janssen Pharmaceutica, Clin Res Report N 9 986Google Scholar
  760. Rossi MA, Bisson FW (1983) Fatal case of multiple liver abscesses caused by adult Ascaris lumbricoides. Am J Trop Med Hyg 32:523–525PubMedGoogle Scholar
  761. Rossignol JF (1981) Albendazol: estudios clinicos realizados en Francia y Africa Occidental. Informe sobre 1,034 casos. Comp de Invert Clin I Simp, vol 1, Latino Americanos Geohelminthiasis y albendazol. Cancun, pp 117–125Google Scholar
  762. Rossignol JF, Coulaud JP (1983) Evaluation of albendazole in Europe, West Africa and Asia as a single dose anthelmintic. Report on 1,455 patients. R Soc Med Int Congress and Symp Ser 57:19–27Google Scholar
  763. Rowland HAK (1966) A comparison of tetrachlorethylene and bephenium hydroxynaph- toate in ancylostomiasis. Trans R Soc Trop Med Hyg 60:313–321PubMedGoogle Scholar
  764. Royer A (1956) Preliminary report on a new antioxyuritic. Can Med Assoc J 74:297–299PubMedGoogle Scholar
  765. Royer A, Baronikoff K (1962) Pinworm infestation in children: the problem and its treatment. Can Med Assoc J 86:60–65PubMedGoogle Scholar
  766. Ruas AO (1973) Mebendazole in the treatment of worm infections. Janssen Pharmaceutica, Clin Res Report, N 7516Google Scholar
  767. Rubens Campos (1982) Tratamento da ascariase e da tricuriase or meio do albendazol. 18e Congr soc Brasil med trop E15Google Scholar
  768. Rubens Campos, Croce J, Amato Neto V (1963) Tratamento da trichostrongiliase humana pelo Tiabendazol. O Hospital 64:261–264Google Scholar
  769. Ruitenberg E J (1970) Anisakiasis: pathogenesis, serodiagnosis and prevention. Thesis, University of Utrecht, p 139Google Scholar
  770. Ruitenberg EJ, Sluiten JF (1974) Trichinella spiralis infections in the Netherlands. In: Kim W (de) Trichinellosis. Proceedings of the 3rd international conference on Trichinellosis. Intext, New YorkGoogle Scholar
  771. Sabharwal DV, Tikare SK, Gupta PS, Chuttani HK (1966) Thiabendazole in hookworm infection. Trans R Soc Trop Med Hyg 60:490–492PubMedGoogle Scholar
  772. Sadun EH, Vajrathira S (1954) The effect of maklua (diospyros mollis) in the treatment of human hookworm. J Parasitol 40:49–53PubMedGoogle Scholar
  773. Sadun EH, Melvin DM, Brooke MM, Carter CH (1956) Evaluation of promethazine hydrochloride R 02–5655/3, phtalylsulfathiazole and piperazine hexahydrate in the treatment of enterobiasis in a mental institution. Am J Trop Med Hyg 5:382–383Google Scholar
  774. Saif M, Bell WJ, Taha A, Abdel-Meguid M, Abdallah A (1971) Comparison of pyrantel pamoate and bephenium hydroxynaphtoate in the treatment of Ancylostoma duodenale infection. J Egypt Med Assoc 54:791–797PubMedGoogle Scholar
  775. Salazar Schettino PM, Haro Ortega (1981) Ensayo clinico doble ciego con Albendazol in Mexico. In: I. Simp latino americano geohelminthiasis y albendazol. Comp de Invest clin Latino americanas, Cancun, pp 90–95Google Scholar
  776. Salem HH, Sherif AF, Abd. Rabbou H, Morcos W, El Niny H (1961) A single dose treatment of enterobiasis by pyrvinium pamoate. J Egypt Public Health Assoc 36:225–234Google Scholar
  777. Salem HH, Hayattee ZG, Awaness AM (1962) Clinical trials with thiabendazole in the treatment of human intestinal helminthiasis. J Trop Med Hyg 11:268–272Google Scholar
  778. Salem HH, Morcos WW, El Niny HM (1965) Clinical trials with bephenium hydroxynaphtoate against A. duodenale and other intestinal helminths. J Trop Med Hyg 68:21–25PubMedGoogle Scholar
  779. Salem HH, Hayatee ZG, Awaness AM, Al-Allaf G (1968) Evaluation of the anthelmintic activity of thiabendazole in man. J Trop Med Hyg 71:11–17PubMedGoogle Scholar
  780. Salunkhe DS, Gaitonde BB, Vakil R (1964) Clinical evaluation of a new anthelminthic thiabendazole [2-(4’thiazolyl) benzimidazole]. Am J Trop Med Hyg 13:412–416PubMedGoogle Scholar
  781. Sanati A, Ghadirian EG (1971) Treatment of enterobiasis with pyrantel pamoate in Iran. J Trop Med Hyg 74:160–161PubMedGoogle Scholar
  782. Sanchez-Carillo CMC, Beltran-Hernandez F (1977) Efectividad terapeutica del fenbenda- zol (Hoe. 881) en las helminthiasis transmitidas por el suelo en el Estado de Chiapas, Mexico. Salud Publica Mex 19:691–700Google Scholar
  783. Sanders A, Hall W (1960) Comparison of dithiazanine iodide and pyrvinium pamoate in the treatment of enterobiasis. J Lab Clin Med 56:413–416PubMedGoogle Scholar
  784. Sandground JH (1929) Ternidens deminutus (Raillet and Henry) as a parasite of man in southern Rhodesia; together with observations and experimental studies on an unidentified nematode parasite of man. Ann Trop Med Parasitol 22:23–29Google Scholar
  785. Sandground JH (1931) Studies on the life-history of Ternidens deminutus, a nematode parasite of man, with observations on its incidence in certain regions of southern Africa. Ann Trop Med Parasitol 25:147–184Google Scholar
  786. San Juan F (1962) A violeta de genciana e o iodeto de ditiazanina na estrongyloidose. Boi Centro Estudos Hosp Servidores Estato 14:195–203Google Scholar
  787. Sanpakit S, Suksungvol S, Bhaibulaya M (1974) Intestinal capillariasis from Sarburi Province, Thailand: report of a second case. J Med Assoc Thai 57:458–460PubMedGoogle Scholar
  788. Sargent RC, Chambers JC (1976) Controlled study comparing levamisole with piperazine citrate and pyrantel pamoate in the treatment of ascariasis. Janssen Pharmaceutica, Clin Res Report N 10 542Google Scholar
  789. Sargent RG, Dudley BW, Fox AS, Lease EJ (1972) Intestinal helminths in children in coastal South Carolina: a problem in southern United States. South Med J 65:294–298PubMedGoogle Scholar
  790. Sargent RG, Savory AM, Mina A, Lee PR (1974) A clinical evaluation of mebendazole in the treatment of trichuriasis. Am J Trop Med Hyg 23:375–377PubMedGoogle Scholar
  791. Sargent RG, Dotterer TD, Savory AM, Lee PR (1975) A clinical evaluation of the efficacy of mebendazole in the treatment of trichuriasis. South Med J 68:38–40PubMedGoogle Scholar
  792. Sauerbrey M (1977) A precipitin test for the diagnosis of human abdominal angiostrongy- liasis. Am J Trop Med Hyg 26:1156–1158PubMedGoogle Scholar
  793. Saugrain J, Delavat A (1970) Bilan de l’action anthelminthique de l’isomère levogyre du Tetramisol en Polynésie Française. Bull Soc Pathol Exot Filiales 63:507–513PubMedGoogle Scholar
  794. Savaton-Pillet J (1957) Personal communication. In: Cavier R (1973) Chemotherapy of intestinal hematodes, chapter 4. Chemotherapy of helmintheasis. Pergamon, OxfordGoogle Scholar
  795. Sawitz WG, Karpinski FE (1956) Treatment of oxyuriasis with pyrroviquinium chloride (Poquil.) Am J Trop Med Hyg 5:538–543PubMedGoogle Scholar
  796. Schenone H, Orfali A, Goldames M, Doren G, Inzunza E, Jimenez M, Romero E, Pinto CG, Anrique B (1974) Tratamiento de las helminthiasis intestinales humanas con mebendazole. Bol. Chil Parasitol 29:2–5PubMedGoogle Scholar
  797. Schenone H, Goldames M, Inzunza E, Jimenez M, Romero E, Bloomfield R (1977) Flu- bendazol en el tratamiento de infecciones por nematodes intestinales en ninos. Bol Chil Parasitol 32:85–86PubMedGoogle Scholar
  798. Schettino SPM, Ortega I de H (1981) Ensayo clinico doble ciego con albendazol en México. Comp Invest Clin Latino Am [Suppl 1] 1:90–95Google Scholar
  799. Schmitz D, Knackfuss BAL (1971) Levamisole na tratamento da ascaridiase en pacientes de grupo etario comprendido entre 1 e 15 anos. Folha Med 63:149–151Google Scholar
  800. Schneider J, Biguet J, Mâchez JM (1960) Traitement de l’oxyurose par le diphétarsone - spiramycine et le diphetarsone. Thérapie 15:648–654PubMedGoogle Scholar
  801. Schräder G (1963) Die Entwicklung neuer insectizider Phosphorsäureester. Verlag Chemie, WeinheimGoogle Scholar
  802. Schreiber W (1959) Intraduodenal therapy for Taenia, hookworm and Strongyloides infection. Gastroenterology 37:346–349PubMedGoogle Scholar
  803. Scragg JN, Proctor EM (1978) Further experience with mebendazole in the treatment of symptomatic trichuriasis in children. Am J Trop Med Hyg 27:255–257PubMedGoogle Scholar
  804. Seah SKK (1976) Mebendazole in the treatment of helminthiasis. Can Med Assoc J 115:777–779PubMedGoogle Scholar
  805. Sen HG (1976) 4-isothiocyanato-4-nitrodiphenylamine (C 9 333–90/CGP 4 540) a new antihelminthic with potent antihookworm activity. Acta Trop 33:101–102Google Scholar
  806. Sen HG, Joshi BS, Parthasarathy FC, Kamat VN (1974) Anthelminthic efficacy of dio- spyrol and its derivatives. Arzneimittelforsch 24:2000–2003PubMedGoogle Scholar
  807. Sentilhes L, Carrie J (1982) Contribution à l’étude l’efficacité et de la tolérance de l’alben- dazole dans le traitement des helminthiases intestinales. Méd Afr Noire 29:33–36Google Scholar
  808. Seo BS (1981) Ascariasis and its control problems in Korea. Seoul J Med 22:323–341Google Scholar
  809. Seo BS, Cho S Y, Chai S Y (1978) Reduced single dose of mebendazole in treatment of Ascaris lumbricoides infection. Korean J Parasitol 16:21–25Google Scholar
  810. Seung Yu-Ch (1977) Study on the quantitative evaluation of reinfection of Ascaris lumbricoides. Kor J Parasitol 15:17–29Google Scholar
  811. Sezi CL (1974) The efficacy of levamisole in hookworm disease. Uganda Med J 3:73–77Google Scholar
  812. Shafei AZ (1955) Piperazine as anthelmintic. Lancet 11:827–828Google Scholar
  813. Shafei AZ (1973) Clinical trials on mebendazole in the treatment of intestinal nematodes. Janssen Pharmaceutica, Clin Res Report N 7 229Google Scholar
  814. Shafei AZ (1974) Clinical trials on mebendazole in the treatment of intestinal nematodes. Janssen Pharmaceutica, Clin Res Report M 8165Google Scholar
  815. Shafei AZ (1976) Clinical trials of mebendazole in the treatment of strongyloidiasis. Jans- sen Pharmaceutica, Clin Res Report N 10494Google Scholar
  816. Shafei AZ, Abaza HH, Hammouda N, Elgohary Y (1971) Clinical trials with compound L 6 842, a new anthelminthic agent. J Egypt Med Assoc 54:361–375PubMedGoogle Scholar
  817. Shah KS, Zaman S (1964) Clinical trials with thiabendazole against human helminths. Pak- istJ Med Res 2:69–105Google Scholar
  818. Shigeo Iwata, Goro-Ueda, Isueneji-Araki, Koichi-Taki, and Takashi-Kageyama (1962) Treatment of ancylostomiasis with bephenium salts in Japan. J Trop Med Hyg 65:9–11Google Scholar
  819. Shiratsuchi MS, Levi GC, Amato Neto V, Avila CA De, Stefani HNV, Mosterio L, Tsu- kumo MKK, Konichi SR, Correa L de L (1975) Tratamento da tricocefaliase pelo mebendazole. Rev Inst Med Trop Sao Paulo 17:206–209PubMedGoogle Scholar
  820. Simionesco O, Lucian O, Ghelber A (1964) Tratamental tricocefalozei en Telmid. Mirco. Parazitol Epidemiol 9:267–271Google Scholar
  821. Singh DS, Bala-Subramanian R, Bhatia VN, Vasantha Kumar, Chandrasekar S (1981) Study of the efficacy of compound 90.9333 (Ciba-Geigy) in hookworm infestation Chemotherapy 27:220–223Google Scholar
  822. Singhai KC, Gupta MC; Saxena PN (1975) A clinical trial with mebendazole in ascariasis and ankylostomiasis. J Assoc Physicians India 23:903–907Google Scholar
  823. Singson CN (1969) Human intestinal capillariasis. Philip J Int Med 7:189–200Google Scholar
  824. Singson CN (1974) Recurrences in human intestinal capillariasis. Philipp J Microbiol Infect Dis 31:7–13Google Scholar
  825. Singson CN, Banzon TC (1969) A preliminary report on levo-tetramisole: a new drug for intestinal capillariasis. J Philipp Med Assoc 45:627–632Google Scholar
  826. Singson CN, Banzon TC, Cross JH (1974) The treatment of human intestinal capillariasis. Janssen Pharmaceutica Clin Res Report N 8 542Google Scholar
  827. Singson CN, Banzon TC, Cross JH (1975) Mebendazole in the treatment of intestinal capillariasis. Am J Trop Med Hyg 24:932–934PubMedGoogle Scholar
  828. Singson CN, Banzon TC, Cross JH (1977) Short term mebendazole treatment for Capillariasis philippensis. J Philipp Med Assoc 53:31–33Google Scholar
  829. Sinniah B, Sinniah D (1981) The anthelmintic effects of pyrantel pamoate, oxantel-pyrantel pamoate, levamisole and mebendazole in the treatment of intestinal nematodes. Ann Trop Med Parasitol 75:315–321PubMedGoogle Scholar
  830. Sinniah B, Sinniah D, Dissanaike AS (1980) Single dose treatment of intestinal nematodes with oxantel-pyrantel pamoate plus mebendazole. Ann Trop Med Parasitol 74:619–623PubMedGoogle Scholar
  831. Soh Ch-Th, Lee BO-H, Min D-Y, Lee JH (1975) Clinical trial of Vermox (mebendazole), a new broad spectrum anthelminthic. Janssen Pharmaceutica Clin Res Report N 8842Google Scholar
  832. Sonnet J J, Thienpont D (1977) The treatment of trichinosis with mebendazole. Acta Clin Belg 32:297–302PubMedGoogle Scholar
  833. Soprunova N, Soprunov FF, Lur’e A A (1973) Nachweis von helminthen Metaboliten im Harn des Wirtes als ein diagnostischer Test für Helminthiases. Angew. Parasitol 14:11- 17Google Scholar
  834. Sornwell RL, Jones RM (1968) Anthelminthic activity of pyrantel pamoate against Ancy- lostoma caninum in dogs. J Trop Med Hyg 71:165–166Google Scholar
  835. Soula G, Siopathis RM (1982) Le zentel dans le traitement des nématodoses en République Centreafricaine. Méd Afr Noire 29:29–32Google Scholar
  836. Spaeth GL, Adams RE, Söffe AH (1964) Treatment of trichinosis. Case report. Arch Ophthalmol 71:359–363PubMedGoogle Scholar
  837. Standen OD (1953) Experimental chemotherapy of oxyuriasis. Br Med J 11:757–758Google Scholar
  838. Steele JH, Schultz MG (1978) Trichinellosis. A review of the current problem. In: Kim CW, Pawlowski ZS (eds) Trichinellosis. New England University Press, Hannover, pp 45–75Google Scholar
  839. Steinrück M, Basener G, Hölzer E (1976) Klinische Erprobung von Vermox’ (mebendazole). Janssen Pharmaceutica Clin Res Report N 19 915Google Scholar
  840. Stemmerman GN, Nakasone N (1980) Strongyloides stercoralis infestation: malabsorption defect with reaction to dithiazanine iodide. JAMA 174:1250–1253Google Scholar
  841. Stewart DF (1955) Self-cure in nematode infestations of sheep. Nature 176:1273–1274PubMedGoogle Scholar
  842. Stoll NR (1923) Investigations on the control of hookworm disease. XV. An effective method of counting hookworm eggs in feces. Am J Hyg 3:59–70Google Scholar
  843. Stoll NR (1947) This wormy world. J Parasitol 33:1–18PubMedGoogle Scholar
  844. Stoll NR (1962) On endemic hookworm. Where do we stand to-day? Exp. Parasitol. 12:241–252Google Scholar
  845. Stoll NR, Hauscher WC (1926) Accuracy in the dilution egg counting method. Am J Hyg [Suppl] 6:80–133,134–145Google Scholar
  846. Stone OJ, Mullins JF (1963) First use of thiabendazole in creeping eruption. Tex Rep Biol Med 21:422–424PubMedGoogle Scholar
  847. Stone OJ, Stone ChT Jr, Mullins FFr (1964) Thiabenazole - probable cure of trichinosis. JAMA 187:536–538PubMedGoogle Scholar
  848. Stott GJ, Jopling WH (1961) Dithiazanine in strongyloidiasis and trichiuriasis. J Trop Med Hyg 64:73–74Google Scholar
  849. Striebel HP (1976) 4-isothiocyanato-4-nitrodiphenylamine (C 9333–90/CGP 4540), an anthelmintic with an unusual spectrum of activity against intestinal nematodes, filarias and schistosomes. Experientia 32:457—458Google Scholar
  850. Stiirchler D, Stahel E, Saladin K, Saladin B (1980) Intestinal parasitoses in eight Liberian settlements: prevalences and community anthelminthic chemotherapy. Tropen med Parasitol 31:87–93Google Scholar
  851. Sun SC, Cross JH, Berg HS, Kau SL, Singson CN, Banzon TC, Watten RH (1974) Ultra- structural studies of intestinal capillariasis. Capillaria philippinensis in human and gerbil hosts. Southeast Asian J Trop Med Public Health 5:524–533PubMedGoogle Scholar
  852. Suzuki R, Yamauchi K, Kobayashi A (1961) Mass treatment of enterobiasis with pyr- vinium pamoate (poquil.). Jpn J Parasitol 10:298–301Google Scholar
  853. Swartzwelder JC, Miller JH, Sappenfield RW (1955) The treatment of cases of ascariasis with piperazine citrate. Am J Trop Med Hyg 4:326–331PubMedGoogle Scholar
  854. Swartzwelder JC, Miller JH, Sappenfield RW (1957 a) The effective use of piperazine for the treatment of human helminthiases. Gastroentrology 33:87–96Google Scholar
  855. Swartzwelder JC, Frye WW, Miihleisen JP, Miller JH, Lampert R, Pena-Chavarria AA, Abadie H, Anthony SO, Sappenfield RW (1957 b) Dithiazanine, an effective broad spectrum anthelmintic. JAMA 165:2063–2067Google Scholar
  856. Swartzwelder JC, Lampert R, Miller JH, Sappenfield RW (1958) Therapy of trichuriasis and ascariasis with dithiazanine. Am J Trop Med Hyg 7:329—333PubMedGoogle Scholar
  857. Swartzwelder JC, Miller JH, Lampert R, Pena-Chavarria A, Abadie SH, Frye WW, Muh- leisen P, Lizano C (1962) Anthelmintic activity of stilbazium iodide (Monopar) against intestinal nematodes in man. J Parasitol 48:29–30Google Scholar
  858. Swartzwelder JC, Abadie SH, Miller JH, Sappenfield RW (1963) Stilbazium iodide (Monopar). An effective, single dose anthelminthic for treatment of Enterobius vermicularis infection. Clin Pediatr 2:701–702Google Scholar
  859. Swellengrebel NH, Sterman MM (1961) Animal parasites in man. D. van Nostrand Co, Princeton, NJGoogle Scholar
  860. Symmers XStC (1950) Pathology of oxyuriasis. Arch Pathol 50:475Google Scholar
  861. Szorady I, Brosody A, Natusovits L (1976) Experiences in the treatment of childhood oxyuriasis with mebendazole (Vermox). Janssen Pharmaceutica, Clin Res Report N 11 118Google Scholar
  862. Takamura S (1963) Fundamental studies on anthelminthics-XV. Jpn J Parasitol 12:147— 150Google Scholar
  863. Takata I (1951) Experimental infections of man with Ascaris of man and the pig. Kitasato Arch Exp Med 23:49–50Google Scholar
  864. Talaat SM (1964) Dipterex: an oral therapeutic agent in the treatment of schistosomiasis and other intestinal parasites. J Egypt Med Assoc 47:589–593PubMedGoogle Scholar
  865. Tanaka H, Shiroma Y, Kumada W, Fukamine K, Kwawamitsu H (1960) An efficacious application of gentian violet to the treatment of human strongyloidiasis. Bull Tokyo Med Dental Univ 7:137–150Google Scholar
  866. Tanaka H, Shiroma Y, Mitsui G (1965) Studies on the treatment of human strongylidiasis with pyrvinium pamoate suspension. Jpn J Parasitol 14:20–26Google Scholar
  867. Tesh RB, Ackerman LJ, Dietz WM, Williams JA (1973) Angiostrongylus costaricensis in Panama. Prevalence and pathologic findings in wild rodents infected with the parasite. Am J Trop Med Hyg 22:348–356PubMedGoogle Scholar
  868. Theodorides VJ, Gyurik RJ, Kingsbury WD, Parisk RC (1976) Anthelmintic activity of albendazole against liver flukes, tapeworms, lung and gastrointestinal roundworms. Experientia 32:702PubMedGoogle Scholar
  869. Thienpont D (1972) Le traitement actuel de la trichocephalose. Acta Gastroenterol Belg 35:439–443Google Scholar
  870. Thienpont D (1976) Le traitement de la trichinose. Nouv Presse Med 5:1759–1760PubMedGoogle Scholar
  871. Thienpont D, Parijs OFJ van, Raeymaekers AHM, Vandenberk J, Demoen PJA, Allewijn FTN, Marsboom RPH, Niemegeers CJE, Schellekens KHL, Janssen PAJ (1966) Tetra- misole (R 8299), a new, potent broad spectrum anthelminthic. Nature 209:1084–1085PubMedGoogle Scholar
  872. Thienpont D, Brugmans J, Abadi K, Tanamal S (1969) Tetramisole in the treatment of nematode infections in man. Am J Trop Med Hyg 18:520–525 Thienpont D, Parijs O van, Niemezeers C, Marsboom R (1978) Biological and pharmacological properties of flubendazole. Arzneimittelforsch 28:605–612Google Scholar
  873. Thomas HW (1910) The pathological report of a case of oesophagostomiasis in man. Ann Trop Med Hyg 5:57–88Google Scholar
  874. Tidball JS, Aguas JP, Aldis JW (1978) A new concentration of human intestinal capillaria- sis on western Luzon. Southeast Asian J Trop Med Public Health 9:33–40PubMedGoogle Scholar
  875. Torna L, Danescu P (1977) Certain aspects of strongyloidiosis in Europe. 1st Med Conf on Parasitology, october, IzmirGoogle Scholar
  876. Torhoudt L (1974) Efficacy of flubendazole in enterobiasis. Janssen Pharmaceutica, Clin Res Report N 9 292Google Scholar
  877. Uchida A, Nozue S, Kaneko IK, Tanaka A, Kondo T, Saito M, Uchida F, Araki T, Karu- be F (1964) Field trials on mass treatment of hookworm infection with bephenium hy- droxynaphtoate. Jpn J Parasitol 13:464–471Google Scholar
  878. Ulyangco C. Reys VM, Cabilong VP, Camacho RC (1968) Capillariasis. J Philip Med Assoc 44:743–757Google Scholar
  879. Undeutsch K, Stumpf J, Landgraf H (1981) Some aspects in the treatment of 25 patients with trichinellosis in Ebermanstadt. In: Kim ChW, Ruitenberg EJ, Teppema JC (eds) Trichinellosis. Reedbooks, Surrey, pp 283–285Google Scholar
  880. Vaidya AB, Sen HG, Mankodi NA, Paul T, Sheth UK (1977) Phase 1, tolerability and searching dose studies with 4-isothiocyanato-4-nitrodiphenylamine (C 9333–90/CGP 4 540), a new anthelminthic. Br J Pharmacol 4:463–467Google Scholar
  881. Vaidya AB, Mankodi NA, Taiwalker Sh, Kale NA, Doshi JC, Paul T, Sheth UK (1981) Cardiovascular function in chronic hookworm anaemie before and after a new anthel- mintic-4-isothiocyanato-4-nitrodiphenylamin. J Assoc Phys Ind 29:279–283Google Scholar
  882. Vakil BJ (1969) Clinical trials with l-tetramisole on school children. Janssen Pharmaceutica, Clin Res Report N 521Google Scholar
  883. Vakil BJ, Dalah NJ (1975) Comparative efficacy of newer anthelminthics. Prog Drug Res 19:166–175PubMedGoogle Scholar
  884. Vakil BJ, Bandisode MS, Gaitonde BB, Salunkhe DS, Kulkarni HJ (1965) Clinical trials with a new anthelminthic: thiabendazole. J Trop Med Hyg 68:287–295PubMedGoogle Scholar
  885. Vakil BJ, Dahal NJ, Gangrade RR, Bhise KB (1972) Clinical trial with l-tetramisole in roundworm and hookworm infection. Trans R Soc Trop Med Hyg 66:250–254PubMedGoogle Scholar
  886. Vakil BJ, Dalai NJ, Enjetti E (1975) Clinical trials with mebendazole, a new broad spectrum anthelminthic. J Trop Med Hyg 78:154–158PubMedGoogle Scholar
  887. Vakil BJ, Dalai NJ, Shah PN (1977) Clinical evaluation of a new anthelmintic (9333–90/ CGP 4 540) in human hookworm infection. Trans R Soc Trop Med Hyg 71:247–250PubMedGoogle Scholar
  888. Vandepitte J, Gatti F, Lontie M, Krubwa F, Nguete M, Thienpont D (1973) Le mebendazole, un nouvel anthelminthique à large spectre très actif contre le trichocéphale. Bull Soc Pathol Exot Filiales 66:165–178 Donckt J Van derGoogle Scholar
  889. Verbruggen F, Heylen G, Parijs O van, Scheygrond H (1975) Double blind comparison of flubendazole and placebo in the treatment of enterobiasis. Janssen Pharmaceutica Clin Res Report R 17 889/4Google Scholar
  890. Van Landuyt H (1973) Levamisole and hookworm in Kinshasa (in Dutch). Janssen Pharmaceutica Clin Res Report N 5 483Google Scholar
  891. Van Landuyt H (1974) Decaris in hookworm disease, ascariasis, trichuriasis and strongyloidiasis. Janssen Pharmaceutica Clin Res Report N 5 483Google Scholar
  892. Vanneste JAL, Ansink BJJ, Snijders CJ, Hölscher JFM (1975) Neurologische bijwerkingen van piperazine. Ned Tijdschr Geneeskd 119:1899–1901PubMedGoogle Scholar
  893. Van Olphen AHF, Nabben FAE (1974) Mebendazole (R 17635) in the treatment of enterobiasis in children. A double blind placebo-controlled study. Janssen Pharmaceutica, Clin Res Report LMD 6 668Google Scholar
  894. Van Thiel PH (1962) Anisakiasis. Parasitology 52:16–17Van Thiel PH (1976) The present state of anisakiasis and its causative worms. Trop Geogr Med 28:75–85Google Scholar
  895. Van Thiel PH, Bakker PM (1981) Gastric worm granulomas in the Netherlands and Japan. Ned Tijdschr Geneeskd 125:1365–1370PubMedGoogle Scholar
  896. Van Thiel PH, Kuipers FC, Roskam RTh (1960) A nematode parasitic to herring, causing acute abdominal syndromes in man. Trop Geogr Med 2:97–113Google Scholar
  897. Vasojevic S, Jevtic M, Suvakovic V (1962) Observations personnelles préliminaires relatives au traitement des strongyloidoses par la dithiazanine. Srpki Arch Celokup lekarst 90:191–195Google Scholar
  898. Venkatachelam PS, Patwardhan VN (1953) The role of Ascaris lumbricoides in the nutrition of the host. Effect of ascariasis on digestion of protein. Trans R Soc Trop Med Hyg 47:169–175Google Scholar
  899. Verwilghen NM (1974) Mebendazole in single and mixed worm infections. Janssen Phar- maceutica, Clin Res Report 1:40Google Scholar
  900. Vik R (1964) Anisakis larvae in Norwegian food fishes. In: Corradetti A (éd) Proc 1st int congr parasitol, Roma. Pergamon, Oxford, pp 568–569Google Scholar
  901. Villarejos VM, Saldana J (1959) Mass deparasitization experiment with dithiazine iodide. Antibiot Med Clin Therapy 6:718–723Google Scholar
  902. Villarejos VM, Arguedas-Gamboa J A, Eduarte E, Swartzwelder JC (1971) Experiences with the anthelminthic pyrantel pamoate. Am J Trop Med Hyg 20:842–845PubMedGoogle Scholar
  903. Villela MP, Rodrigues LD, Capell JI, Brandao J A, Martirani I, Zucato M (1962) O empri- go do thiabendazol no tratamento da estrongiloidiase e de outras parasitosis humanas. O Hospital 62:691–710Google Scholar
  904. Villela MP, Zucato M, Nascimento SR (1964) Tratamento da tricocefaliase intestinal pelo pamoate de pirvino. O Hospital 66:151–153Google Scholar
  905. Villela MP, Zucas AW, Iglesias J (1968) The therapy of trichiuriasis with a combination of thiabendazole and pyrvinium pamoate. O Hospital 68:1413–1418Google Scholar
  906. Vinke B, Sar A Van der (1959) Dithiazanine, a new anthelmintic. Trop Geogr Med 11:335- 338Google Scholar
  907. Vujosevic M, Kostic A, Lalic R, Zerjav S (1979) Mebendazole (Vermox) in the treatment of Trichinella spiralis infections. In: 3rd Congr Yugoslav. Infectiologists, pp 213–215Google Scholar
  908. Wagner ED (1963) Pyrvinium pamoate in the treatment of strongyloidiasis. Am J Trop Med Hyg 12:60–61PubMedGoogle Scholar
  909. Wagner ED, Rexinger DD (1978) In vivo effects of mebendazole und levamisole in the treatment of trichuriasis and ascariasis. Am J Trop Med Hyg 27:203–205PubMedGoogle Scholar
  910. Wagner ED, Lemon FR, Burnett HS (1958) The use of dithiazanine in the treatment of helminthiasis in Mexican farm labourers. Am J Trop Med Hyg 7:600–602PubMedGoogle Scholar
  911. Walfe M J, Wershing JM (1974) Mebendazole treatment of trichuriasis and ascariasis in Bahamian children. JAMA 230:1408–1411Google Scholar
  912. Wang CC, Galli GA (1965) Strongyloidiasis treated with pyrvinium pamoate. JAMA 193:847–848PubMedGoogle Scholar
  913. Wang Ch-I, Hu Hs-J, Wang H-Hs, Peng YF (1964) The anthelminthic effects of bephenium hydroxynaphtoate on hookworm and other nematode infections of the intestinal tract. Chin Med J 83:1–10PubMedGoogle Scholar
  914. Watson JM (1960) Medical helminthology. Ballière Tindall Cox, LondonGoogle Scholar
  915. Watten RH, Beckner WM, Cross JH, Cunning J-J, Jarimillo J (1972) Clinical studies on Capillariasisphilippinensis. Trans R Soc Trop Med Hyg 66:828–834PubMedGoogle Scholar
  916. Webb JL (1937) The helminth of the intestinal canal in man in Mauritius; and a first record of Trichostrongylus axei locally. Parasitology 29:469–476Google Scholar
  917. Wellens D, Thienpont D (1978) Mebendazole (Vermox) for chemotherapy of intestinal helminths. Med Digest 4:23–27Google Scholar
  918. Weng L-Ch, Mao Sh-G, Liu Er-Hs (1960) Research on parasitic diseases in New China. Chin Med J 80:1–20Google Scholar
  919. Wershing JM, Wolfe MS, Burke FG (1975) Placebo-controlled comparison of levamisole, pyrantel pamoate, thiabendazole, piperazine citrate and various dosages of mebendazole in the treatment of ascariasis and trichuriasis in children. Janssen Pharmaceutic, Clin Res Report N 10422Google Scholar
  920. Wershing JM, Burke FG, Wolfe MS (1979) Dose range study of flubendazole in children with Ascaris lumbricoides and/or Trichuris trichiura infections. Janssen Pharmaceutica, Clin Res Report R 17 889/14Google Scholar
  921. Whalen GE, Strickland GT, Cross JH, Uylangco C, Rosenberg EB, Gutman RA, Watten RH, Dizon JJ (1969) Intestinal capillariasis - a new disease in man. Lancet 1:13–16PubMedGoogle Scholar
  922. Whalen GE, Rosenberg EG, Gutman RA, Cross JH, Fresh JW, Strickland T, Uylangco S (1971) Treatment of intestinal capillariasis with thiabendazole, bithionol and bephenium. Am J Trop Med Hyg 20:95–100PubMedGoogle Scholar
  923. White RHR, Scopes JW (1960) A single dose treatment of threadworm in children. Lancet 278:256–257Google Scholar
  924. White RHR, Standen OD (1953) Piperazine in the treatment of threadworms in children. Br Med J 755–757 WHO (1964) Soil transmitted helminths. WHO Tech Rep Ser 277 WHO (1967) Control of ascariasis. WHO Tech Rep Ser 379Google Scholar
  925. Winsor EL, Totten JC (1976) Controlled study comparing levamisole with piperazine citrate in the treatment of ascariasis in children. Janssen Pharmaceutica, Clin Res Report N 10571Google Scholar
  926. Wolfe MS, Wershing JM (1974) Mebendazole: treatment of trichuriasis and ascariasis in Bahamian Children. JAMA 230:1408–1411PubMedGoogle Scholar
  927. Wollweber H, Niemers E, Flucke W, Andrews P, Schulz HP, Thomas H (1979) Amidantel, a potent anthelmintic from a new chemical class. Arzneimittelforsch 29:31–32PubMedGoogle Scholar
  928. Wright WH, Brady FJ (1938) Studies on oxyuriasis. A preliminary note on therapy with gentian violet. Proc Helminthol Soc 5:5–7Google Scholar
  929. Wright WH, Brady FJ (1940) Studies on oxyuriasis. JAMA 114:861–866Google Scholar
  930. Yalcinkaya F (1977) A polivalent anthelminthic mebendazole. In: 1st Med conf on para- sitol. Izmyr, october 5–10, p 122Google Scholar
  931. Yanagisawa T (1957) Rinsko shokakibyogaku 5:41–42 (in Japanese)Google Scholar
  932. Yangco B, Klein T (1980) Single-blind comparison of flubendazole with mebendazole in the treatment of trichuriasis and hookworm disease. Janssen Pharmaceutica, Clin Res Report N 21275Google Scholar
  933. Yangco BG, Klein TRW, Deresinski SC, Vickery AC, Graig ChP (1981) Flubendazole and mebendazole in the treatment of trichuriasis and other helminthiasis. Clin Ther 4:285–290PubMedGoogle Scholar
  934. Yoeli M, Most H, Beruan HH, Tesse BI (1963) The problems of strongyloidiasis among the mentally retarded in institutions. Trans R Soc Trop Med Hyg 57:336—345PubMedGoogle Scholar
  935. Yokogawa M, Yosmimura H (1967) Clinicopathologic studies on larval anisakiasis in Japan. Am J Trop Med Hyg 16:723–728PubMedGoogle Scholar
  936. Yokogawa M, Yoshimura H, Sano M, Araki K, Koyama H, Furusawa H (1968) Mass treatment of human trichuriasis with stilbasium iodide. Jpn J Parasitol 17:27–35Google Scholar
  937. Yokogawa M, Araki K, Kojima S, Niimura M, Ogawa K (1970) Clinical evaluation of a new antihelmintic, pyrantel pamoate in hookworm infection. Jpn J Parasitol 19:301–306Google Scholar
  938. Yokogawa M, Sano M, Saito K (1976) Anthelminthic efficacy of mebendazole for trichuriasis. Jpn J Parasitol 25:16–18Google Scholar
  939. Yoshida Y, Nakanishi Y, Shimatani T, Matuo K (1960) Comparative studies on the anthelminthic effect of bephenium hydroxynaphtoate, tetrachlorethylene, l-bromo-?-naph- tol and 4-iodothymol against human hookworm. Jpn J Parasitol 9:620–628Google Scholar
  940. Young MD, Freed JE (1956) The effect of puromycin against E. histolytica and other intestinal parasites. South Med J 49:537–538Google Scholar
  941. Young MD, Jeffery GM, Freed JE, Morehouse WG (1958) Bephenium a new active drug against human hookworm. J Parasitol 44:611–612PubMedGoogle Scholar
  942. Young MD, Jeffery GM, Morehouse WG, Freed JE, Johnson RS (1960) The comparative efficacy of bephenium hydroxynaphtoate and tetrachlorethylene against hookworm and other parasites. Am J Trop Med Hyg 9:488–490PubMedGoogle Scholar
  943. Zahedi M, Oothuman P, Sabapathy NN, Bakar NA (1980) Intestinal nematode infections and efficacy study of oxantel-pyrantel pamoate among plantation workers. Med J Malaysia 35:31–37PubMedGoogle Scholar
  944. Zakine J, Zakine CI (1960) Essais thérapeutiques dans l’ankylostomose en Tunisie par un dérivé quaternaire de l’ammonium. Bull Soc Pathol Exot Filiales 53:314–321PubMedGoogle Scholar
  945. Zaman Y, Loh YP (1974) Clinical trial of pyrantel embonate, levotetramisol and be- phenium hydroxynaphtoate against Necator americanus. Singapore Med J 15:147–148PubMedGoogle Scholar
  946. Zimmermann WJ, Zinter DE (1971) The prevalence of trichuriasis in swine in the United States, 1966–1970. Health Serv Rep 86:937–943Google Scholar
  947. Zimmermann WJ, Steele JH, Kagan IG (1973) Trichuriasis in the US population 1966—1970, prevalence epidemologic factors. Health Serv Rep 88:606–623PubMedGoogle Scholar
  948. Zucato M, Vilela MP (1964) Tratamento da tricocefaliose intestinal pelo tiabendazol. J Bras Med 8:1219Google Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1985

Authors and Affiliations

  • P. G. Janssens

There are no affiliations available

Personalised recommendations